TY 2013 Form 990

(A) Name and business address	(B) Description of services	(C) Compensation
CG ASSOCIATES, 7 CHUCK DRIVE UNIT CDRACUTMA01826	CONSTRUCTION	641,053
FISH AND RICHARDSON PC, PO BOX 3295BOSTONMA02241	LEGAL SERVICES	469,200
LFREP SERVICES LLC, 260 FRANKLIN STREETBOSTONMA02110	DEVELOPMENT SERVICES	447,631
PRICEWATERHOUSECOOPERS LLP, PO BOX 7247-8001PHILADELPHIAPA19103	AUDIT SERVICES	400,129
GOODWIN PROCTER, EXCHANGE PLACE 53 STATE STREETBOSTONMA02109	LEGAL SERVICES	228,885
2 Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization 14

Do not include amounts reported on lines 6b, 7b, 8b, 9b, and 10b of Part VIII.	(A) Total expenses	(B) Program service expenses	(C) Management and general expenses	(D) Fundraising expenses
1	Grants and other assistance to governments and organizations in the United States. See Part IV, line 21	17,733,499	17,733,499
2	Grants and other assistance to individuals in the United States. See Part IV, line 22	0	0
3	Grants and other assistance to governments, organizations, and individuals outside the United States. See Part IV, lines 15 and 16	64,739	64,739
4	Benefits paid to or for members	0	0
5	Compensation of current officers, directors, trustees, and key employees ....	2,848,724	1,073,594	1,560,489	214,641
6	Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) ....	0	0
7	Other salaries and wages	79,913,592	61,302,167	17,559,460	1,051,965
8	Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) ....	1,526,099	1,166,568	331,906	27,625
9	Other employee benefits .......	12,495,092	9,551,393	2,717,516	226,183
10	Payroll taxes ...........	6,833,243	5,223,410	1,486,139	123,694
11	Fees for services (non-employees):
a	Management ......	0	0
b	Legal .........	944,895	755,961	188,934	0
c	Accounting ...........	496,758	146,868	349,890	0
d	Lobbying ...........	126,000	0	126,000	0
e	Professional fundraising services. See Part IV, line 17	190,046			190,046
f	Investment management fees ......	0	0
g	Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O) ........	3,407,794	2,884,119	523,675	0
12	Advertising and promotion ....	1,002,119	9,973	992,146	0
13	Office expenses .......	2,061,524	1,160,403	794,588	106,533
14	Information technology ......	2,849,549	0	2,849,549	0
15	Royalties ..	0	0
16	Occupancy ...........	12,120,735	892,910	11,227,825	0
17	Travel ............	1,196,464	805,778	358,604	32,082
18	Payments of travel or entertainment expenses for any federal, state, or local public officials ......	0	0
19	Conferences, conventions, and meetings ....	0	0
20	Interest ...........	2,470,354	1,623,306	847,048	0
21	Payments to affiliates .......	0	0
22	Depreciation, depletion, and amortization .....	18,751,456	12,321,860	6,429,596	0
23	Insurance ..............	1,244,992	68,514	1,176,478	0
24	Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a	MEDICAL SUPPLIES	34,457,027	34,330,104	126,923	0
b	PHYSICIANS ADMINISTRATION	5,422,250	5,328,970	93,280	0
c	MISCELLANEOUS	9,613,421	6,177,044	3,280,847	155,530
d	ALL OTHER EXPENSES	10,290,898	4,646,777	5,627,095	17,026
e	All other expenses
25	Total functional expenses. Add lines 1 through 24e	228,061,270	167,267,957	58,647,988	2,145,325
26	Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here if following SOP 98-2 (ASC 958-720).

Part X Balance Sheet Check if Schedule O contains a response or note to any line in this Part X ..............
	1	Cash–non-interest-bearing .............	1,374,003	1	566,415
2	Savings and temporary cash investments .........	0	2	0
3	Pledges and grants receivable, net ...........	0	3	360,000
4	Accounts receivable, net .............	21,380,084	4	22,892,699
5	Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L ..................
		10,000	5	10,000
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L
		0	6	0
7	Notes and loans receivable, net .............	0	7	0
8	Inventories for sale or use ..............	2,302,498	8	3,028,866
9	Prepaid expenses and deferred charges ..........	4,078,975	9	4,195,936
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a	391,123,990
b	Less: accumulated depreciation .....	10b	255,776,662	138,441,661	10c	135,347,328
11	Investments—publicly traded securities ..........	0	11	0
12	Investments—other securities. See Part IV, line 11 .....	0	12	0
13	Investments—program-related. See Part IV, line 11 .....	0	13	0
14	Intangible assets ...............	0	14	0
15	Other assets. See Part IV, line 11 ...........	56,462,194	15	42,798,508
16	Total assets. Add lines 1 through 15 (must equal line 34)......	224,049,415	16	209,199,752
	17	Accounts payable and accrued expenses .........	70,433,190	17	77,351,461
18	Grants payable .................	0	18	0
19	Deferred revenue ................	25,513,725	19	14,295,172
20	Tax-exempt bond liabilities .............	83,647,571	20	80,998,192
21	Escrow or custodial account liability. Complete Part IV of Schedule D..	0	21	0
22	Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
	persons. Complete Part II of Schedule L..........	0	22	0
23	Secured mortgages and notes payable to unrelated third parties ..	0	23	0
24	Unsecured notes and loans payable to unrelated third parties ....	0	24	0
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D....................	7,935,144	25	8,020,370
26	Total liabilities. Add lines 17 through 25.........	187,529,630	26	180,665,195
		Organizations that follow SFAS 117 (ASC 958), check here and complete lines 27 through 29, and lines 33 and 34.
27	Unrestricted net assets ..............	36,519,785	27	28,174,557
28	Temporarily restricted net assets ...........	0	28	360,000
29	Permanently restricted net assets ...........	0	29	0
	Organizations that do not follow SFAS 117 (ASC 958), check here and complete lines 30 through 34.
30	Capital stock or trust principal, or current funds ........		30
31	Paid-in or capital surplus, or land, building or equipment fund .....		31
32	Retained earnings, endowment, accumulated income, or other funds		32
33	Total net assets or fund balances ...........	36,519,785	33	28,534,557
34	Total liabilities and net assets/fund balances ........	224,049,415	34	209,199,752

- TIN:

SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service

Public Charity Status and Public Support

Complete if the organization is a section 501(c)(3) organization or a section 4947(a)(1) nonexempt charitable trust.

Attach to Form 990 or Form 990-EZ. right arrow

See separate instructions.
right arrow

Information about Schedule A (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public
Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Reason for Public Charity Status (All organizations must complete this part.) See instructions.

The organization is not a private foundation because it is: (For lines 1 through 11, check only one box.)

A church, convention of churches, or association of churches described in section 170(b)(1)(A)(i).

A school described in section 170(b)(1)(A)(ii). (Attach Schedule E.)

A hospital or a cooperative hospital service organization described in section 170(b)(1)(A)(iii).

A medical research organization operated in conjunction with a hospital described in section 170(b)(1)(A)(iii). Enter the hospital's name, city, and state:

An organization operated for the benefit of a college or university owned or operated by a governmental unit described in

section 170(b)(1)(A)(iv). (Complete Part II.)

A federal, state, or local government or governmental unit described in section 170(b)(1)(A)(v).

An organization that normally receives a substantial part of its support from a governmental unit or from the general public described in section 170(b)(1)(A)(vi). (Complete Part II.)

A community trust described in section 170(b)(1)(A)(vi). (Complete Part II.)

An organization that normally receives: (1) more than 331/3% of its support from contributions, membership fees, and gross

receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 331/3% of

its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses

acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)

An organization organized and operated exclusively to test for public safety. See section 509(a)(4).

An organization organized and operated exclusively for the benefit of, to perform the functions of, or to carry out the purposes of one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2). See section 509(a)(3). Check the box that describes the type of supporting organization and complete lines 11e through 11h.

Type I

Type II

Type III - Functionally integrated

Type III - Non-functionally integrated

By checking this box, I certify that the organization is not controlled directly or indirectly by one or more disqualified persons other than foundation managers and other than one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2).

If the organization received a written determination from the IRS that it is a Type I, Type II, or Type III supporting organization, check this box ..................................................

Since August 17, 2006, has the organization accepted any gift or contribution from any of the
following persons?

(i) A person who directly or indirectly controls, either alone or together with persons described in (ii)

Yes

and (iii) below, the governing body of the supported organization? ................

11g(i)

(ii) A family member of a person described in (i) above? ......................

11g(ii)

(iii) A 35% controlled entity of a person described in (i) or (ii) above? ................

11g(iii)

Provide the following information about the supported organization(s).

(i) Name of supported organization	(ii) EIN	(iv) Is the organization in col. (i) listed in your governing document?		(v) Did you notify the organization in col. (i) of your support?		(vi) Is the organization in col. (i) organized in the U.S.?		(vii) Amount of monetary support
(i) Name of supported organization	(ii) EIN	Yes	No	Yes	No	Yes	No	(vii) Amount of monetary support


Total

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990EZ.

Cat. No. 11285F

Schedule A (Form 990 or 990-EZ) 2013

Page 2

Part II

Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2009	(b) 2010	(c) 2011	(d) 2012	(e) 2013	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") ....	39,220,406	37,417,260	33,572,100	39,413,484	41,532,901	191,156,151
2	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.......						0
3	The value of services or facilities furnished by a governmental unit to the organization without charge..						0
4	Total. Add lines 1 through 3	39,220,406	37,417,260	33,572,100	39,413,484	41,532,901	191,156,151
5	The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f)..						0
6	Public support. Subtract line 5 from line 4.						191,156,151

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2009	(b) 2010	(c) 2011	(d) 2012	(e) 2013	(f) Total
7	Amounts from line 4..	39,220,406	37,417,260	33,572,100	39,413,484	41,532,901	191,156,151
8	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources...	13,360,234	11,313,782	15,165,483	16,370,797	14,057,593	70,267,889
9	Net income from unrelated business activities, whether or not the business is regularly carried on..						0
10	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.)..	733,262	1,457,363				2,190,625
11	Total support (Add lines 7 through 10).						263,614,665

Gross receipts from related activities, etc. (see instructions) ..................

802,149,364

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a 501(c)(3) organization, check this box and stop here................................................. right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2013 (line 6, column (f) divided by line 11, column (f)) .........

72.513 %

Public support percentage for 2012 Schedule A, Part II, line 14 ...............

0 %

16a

33 1/3% support test—2013. If the organization did not check the box on line 13, and line 14 is 33 1/3% or more, check this box
and stop here. The organization qualifies as a publicly supported organization ....................... right arrow

33 1/3% support test—2012. If the organization did not check a box on line 13 or 16a, and line 15 is 33 1/3% or more, check this
box and stop here. The organization qualifies as a publicly supported organization ..................... right arrow

17a

10%-facts-and-circumstances test—2013. If the organization did not check a box on line 13, 16a, or 16b, and line 14
is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here. Explain
in Part IV how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly supported
organization ..................................................... right arrow

10%-facts-and-circumstances test—2012. If the organization did not check a box on line 13, 16a, 16b, or 17a, and line
15 is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here.
Explain in Part IV how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly
supported organization ................................................ right arrow

Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow

Schedule A (Form 990 or 990-EZ) 2013

Page 3

Part III

Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 9 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2009	(b) 2010	(c) 2011	(d) 2012	(e) 2013	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .
2	Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose......
3	Gross receipts from activities that are not an unrelated trade or business under section 513..
4	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...
5	The value of services or facilities furnished by a governmental unit to the organization without charge..
6	Total. Add lines 1 through 5.
7a	Amounts included on lines 1, 2, and 3 received from disqualified persons...
b	Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.
c	Add lines 7a and 7b..
8	Public support (Subtract line 7c from line 6.)

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2009	(b) 2010	(c) 2011	(d) 2012	(e) 2013	(f) Total
9	Amounts from line 6...
10a	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..
b	Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.
c	Add lines 10a and 10b.
11	Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.
12	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.) ..
13	Total support. (Add lines 9, 10c, 11, and 12.)..

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a 501(c)(3) organization,
check this box and stop here............................................. right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2013 (line 8, column (f) divided by line 13, column (f)) .........

Public support percentage from 2012 Schedule A, Part III, line 15 ...............

Section D. Computation of Investment Income Percentage

Investment income percentage for 2013 (line 10c, column (f) divided by line 13, column (f)) ......

Investment income percentage from 2012 Schedule A, Part III, line 17 .............

19a

33 1/3% support tests—2013. If the organization did not check the box on line 14, and line 15 is more than 33 1/3%, and line 17 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ........ right arrow

33 1/3% support tests—2012. If the organization did not check a box on line 14 or line 19a, and line 16 is more than 33 1/3% and line 18 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ..... right arrow

Private foundation. If the organization did not check a box on line 14, 19a, or 19b, check this box and see instructions ..... right arrow

Schedule A (Form 990 or 990-EZ) 2013

Page 4

Part IV

Supplemental Information. Provide the explanations required by Part II, line 10; Part II, line 17a or 17b; and Part III, line 12. Also complete this part for any additional information. (See instructions).

Facts And Circumstances Test

Explanation

Schedule A (Form 990 or 990-EZ) 2013

Additional Data

Software ID:
Software Version:

- TIN:

Schedule B
(Form 990, 990-EZ,
or 990-PF)

Department of the Treasury
Internal Revenue Service

Schedule of Contributors

Attach to Form 990, 990-EZ, or 990-PF.

Information about Schedule B (Form 990, 990-EZ, or 990-PF) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Organization type (check one):

Filers of:

Section:

Form 990 or 990-EZ

501(c)( ) (enter number) organization

4947(a)(1) nonexempt charitable trust not treated as a private foundation

527 political organization

Form 990-PF

501(c)(3) exempt private foundation

4947(a)(1) nonexempt charitable trust treated as a private foundation

501(c)(3) taxable private foundation

Check if your organization is covered by the General Rule or a Special Rule.
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.

General Rule

For an organization filing Form 990, 990-EZ, or 990-PF that received, during the year, $5,000 or more (in money or
property) from any one contributor. Complete Parts I and II.

Special Rules

For a section 501(c)(3) organization filing Form 990 or 990-EZ that met the 33¹/3% support test of the regulations
under sections 509(a)(1) and 170(b)(1)(A)(vi) and received from any one contributor, during the year, a contribution of the
greater of (1) $5,000 or (2) 2% of the amount on (i) Form 990, Part VIII, line 1h, or (ii) Form 990-EZ, line 1. Complete Parts I and II.

For a section 501(c)(7), (8), or (10) organization filing Form 990 or 990-EZ that received from any one contributor,
during the year, total contributions of more than $1,000 for use exclusively for religious, charitable,
scientific, literary, or educational purposes, or for the prevention of cruelty to children or animals. Complete Parts I, II, and
III.

For a section 501(c)(7), (8), or (10) organization filing Form 990 or 990-EZ that received from any one contributor,
during the year, contributions for use exclusively for religious, charitable, etc., purposes, but these contributions did
not total more than $1,000. If this box is checked, enter here the total contributions that were received during
the year for an exclusively religious, charitable, etc., purpose. Do not complete any of the parts unless the General Rule
applies to this organization because it received nonexclusively religious, charitable, etc., contributions of $5,000 or more
during the year ......................... Arrow Bullet

Caution. An organization that is not covered by the General Rule and/or the Special Rules does not file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its
Form 990-EZ or on its Form 990PF, Part I, line 2, to certify that it does not meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).

For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.

Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2013)

Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Page 2

Name of organization MASSACHUSETTS EYE & EAR INFIRMARY

Part I	Contributors (see instructions). Use duplicate copies of Part I if additional space is needed.
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
RESTRICTED	RESTRICTED RESTRICTED RESTRICTED RESTRICTED, RESTRICTEDRESTRICTED	$RESTRICTED	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Page 3

Name of organization MASSACHUSETTS EYE & EAR INFIRMARY

Part II	Noncash Property (see instructions). Use duplicate copies of Part II if additional space is needed.
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (see instructions)	(d) Date received
		$
Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Page 4

Name of organization
MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part III

Exclusively religious, charitable, etc., individual contributions to section 501(c)(7), (8), or (10) organizations
that total more than $1,000 for the year. Complete columns (a) through (e) and the following line entry.
For organizations completing Part III, enter the total of exclusively religious, charitable, etc.,
contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet

$
Use duplicate copies of Part III if additional space is needed.

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a) No.
from
Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE C
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527
SchCMd Bullet

Complete if the organization is described below. SchCMd Bullet

Attach to Form 990 or Form 990-EZ.
SchCMd Bullet

See separate instructions. SchCMd Bullet

Information about Schedule C (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public
Inspection

If the organization answered "Yes" to Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet

Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet

Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet

Section 527 organizations: Complete Part I-A only.
If the organization answered "Yes" to Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet

Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)): Complete Part II-A. Do not complete Part II-B.
Round Bullet

Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered "Yes" to Form 990, Part IV, Line 5 (Proxy Tax) or Form 990-EZ, Part V, line 35c (Proxy Tax), then
Round Bullet

Section 501(c)(4), (5), or (6) organizations: Complete Part III.

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I-A

Complete if the organization is exempt under section 501(c) or is a section 527 organization.

Provide a description of the organization’s direct and indirect political campaign activities in Part IV.

Political expenditures .................................... SchCMd Bullet

Volunteer hours ........................................

Part I-B

Complete if the organization is exempt under section 501(c)(3).

Enter the amount of any excise tax incurred by the organization under section 4955 ......... SchCMd Bullet

Enter the amount of any excise tax incurred by organization managers under section 4955 ...... SchCMd Bullet

If the organization incurred a section 4955 tax, did it file Form 4720 for this year? ..............

Yes No

Was a correction made? .........................................

Yes No

If "Yes," describe in Part IV.

Part I-C

Complete if the organization is exempt under section 501(c), except section 501(c)(3).

Enter the amount directly expended by the filing organization for section 527 exempt function activities SchCMd Bullet

Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt function activities ................................... SchCMd Bullet

Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b.. SchCMd Bullet

Did the filing organization file Form 1120-POL for this year? ..........................

Yes No

Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.

(a) Name	(b) Address	(c) EIN	(d) Amount paid from filing organization's funds. If none, enter -0-.	(e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.

For Paperwork Reduction Act Notice, see the instructions for Form 990 or 990-EZ.

Cat. No. 50084S

Schedule C (Form 990 or 990-EZ) 2013

Page 2

Part II-A

Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).

A Check SchCMd Bullet

if the filing organization belongs to an affiliated group (and list in Part IV each affiliated group member's name, address, EIN, expenses, and share of excess lobbying expenditures).
B Check SchCMd Bullet

if the filing organization checked box A and "limited control" provisions apply.

Limits on Lobbying Expenditures (The term "expenditures" means amounts paid or incurred.)		(b) Affiliated group totals
1a	Total lobbying expenditures to influence public opinion (grass roots lobbying) ......
b	Total lobbying expenditures to influence a legislative body (direct lobbying) .......
c	Total lobbying expenditures (add lines 1a and 1b) ...................
d	Other exempt purpose expenditures ........................
e	Total exempt purpose expenditures (add lines 1c and 1d) ...............
f	Lobbying nontaxable amount. Enter the amount from the following table in both columns.
	If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:
	Not over $500,00020% of the amount on line 1e.
	Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.
	Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.
	Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.
	Over $17,000,000$1,000,000.

g	Grassroots nontaxable amount (enter 25% of line 1f) .................
h	Subtract line 1g from line 1a. If zero or less, enter -0-. ................
i	Subtract line 1f from line 1c. If zero or less, enter -0-. ................
j	If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting section 4911 tax for this year? ......................................	Yes No

4-Year Averaging Period Under Section 501(h) (Some organizations that made a section 501(h) election do not have to complete all of the five columns below. See the instructions for lines 2a through 2f on page 4.)
Lobbying Expenditures During 4-Year Averaging Period
	Calendar year (or fiscal year beginning in)	(a) 2010	(b) 2011	(c) 2012	(d) 2013	(e) Total

2a	Lobbying nontaxable amount

b	Lobbying ceiling amount (150% of line 2a, column(e))

c	Total lobbying expenditures

d	Grassroots nontaxable amount

e	Grassroots ceiling amount (150% of line 2d, column (e))

f	Grassroots lobbying expenditures

Schedule C (Form 990 or 990-EZ) 2013

Page 3

Part II-B

Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).

For each "Yes" response to lines 1a through 1i below, provide in Part IV a detailed description of the lobbying activity.

(a)

Yes

(b)

Amount

During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:

Volunteers? .........................................

Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ....

Yes

Media advertisements? ....................................

Mailings to members, legislators, or the public? .........................

Yes

Publications, or published or broadcast statements? .......................

Grants to other organizations for lobbying purposes? .......................

Direct contact with legislators, their staffs, government officials, or a legislative body? ........

Yes

126,000

Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ......

Other activities? ..........................

Total. Add lines 1c through 1i ...............................

126,000

Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....

If "Yes," enter the amount of any tax incurred under section 4912 .................

If "Yes," enter the amount of any tax incurred by organization managers under section 4912 .....

If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? .......

Part III-A

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).

Yes

Were substantially all (90% or more) dues received nondeductible by members? ................

Did the organization make only in-house lobbying expenditures of $2,000 or less? ................

Did the organization agree to carry over lobbying and political expenditures from the prior year? ..........

Part III-B

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) and if either (a) BOTH Part III-A, lines 1 and 2, are answered "No" OR (b) Part III-A, line 3, is answered “Yes."

Dues, assessments and similar amounts from members .....................

Section 162(e) nondeductible lobbying and political expenditures (do not include amounts of political
expenses for which the section 527(f) tax was paid).

Current year .........................................

Carryover from last year ....................................

Total ............................................

Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .

If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ................................

Taxable amount of lobbying and political expenditures (see instructions) ..............

Part IV

Supplemental Information

Provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, line 5; Part II-A (affiliated group list); Part II-A, line 2; and Part ll-B, line 1. Also, complete this part for any additional information.

Return Reference	Explanation
SCHEDULE C, PART II-B, LINE 1(I):	During Fiscal Year 2014, Mass. Eye and Ear paid consulting fees for assistance with advocacy for a state bill that authorized the hospital to negotiate with the state of Massachusetts for a land lease. This bill passed and was signed in July/August of 2014. Additionally, these paid consultants assisted with developing state and federal legislative strategies, and served as a liaison to government agencies as necessary and monitor and report on government programs relative to healthcare financing, including state appropriations and grants. Mass. Eye and Ear is a member of certain trade associations they may lobby on its behalf.

Return Reference

Explanation

SCHEDULE C, PART II-B, LINE 1(I):

During Fiscal Year 2014, Mass. Eye and Ear paid consulting fees for assistance with advocacy for a state bill that authorized the hospital to negotiate with the state of Massachusetts for a land lease. This bill passed and was signed in July/August of 2014. Additionally, these paid consultants assisted with developing state and federal legislative strategies, and served as a liaison to government agencies as necessary and monitor and report on government programs relative to healthcare financing, including state appropriations and grants. Mass. Eye and Ear is a member of certain trade associations they may lobby on its behalf.

Schedule C (Form 990 or 990EZ) 2013

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE D
(Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Financial Statements

Complete if the organization answered "Yes," to Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b
SchDMd Bullet

Attach to Form 990. SchDMd Bullet

See separate instructions. SchDMd Bullet

Information about Schedule D (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" to Form 990, Part IV, line 6.

		(a) Donor advised funds	(b) Funds and other accounts
1	Total number at end of year .........
2	Aggregate contributions to (during year) ...
3	Aggregate grants from (during year) .....
4	Aggregate value at end of year ........

Did the organization inform all donors and donor advisors in writing that the assets held in donor advised
funds are the organization's property, subject to the organization's exclusive legal control? ............

Yes No

Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be
used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................

Yes No

Part II

Conservation Easements. Complete if the organization answered "Yes" to Form 990, Part IV, line 7.

Purpose(s) of conservation easements held by the organization (check all that apply).

Preservation of land for public use (e.g., recreation or education) Preservation of an historically important land area

Protection of natural habitat Preservation of a certified historic structure

Preservation of open space

Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.


a	Total number of conservation easements .......................	2a
b	Total acreage restricted by conservation easements ..................	2b
c	Number of conservation easements on a certified historic structure included in (a) .....	2c
d	Number of conservation easements included in (c) acquired after 8/17/06, and not on a historic structure listed in the National Register ....................	2d

Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during
the tax year SchDMd Bullet

Number of states where property subject to conservation easement is located SchDMd Bullet

Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and
enforcement of the conservation easements it holds? .............................

Yes No

Staff and volunteer hours devoted to monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet

Amount of expenses incurred in monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet

Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .......................................

Yes No

In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" to Form 990, Part IV, line 8.

If the organization elected, as permitted under SFAS 116 (ASC 958), not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.

If the organization elected, as permitted under SFAS 116 (ASC 958), to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:

(i)

Revenues included in Form 990, Part VIII, line 1 ........................ SchDMd Bullet

(ii)

Assets included in Form 990, Part X .............................. SchDMd Bullet

If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 (ASC 958) relating to these items:

Revenues included in Form 990, Part VIII, line 1 .......................... SchDMd Bullet

Assets included in Form 990, Part X ............................... SchDMd Bullet

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 52283D

Schedule D (Form 990) 2013

Page 2

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)

Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):

Public exhibition

Loan or exchange programs

Scholarly research

Other

Preservation for future generations

Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.

During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?........

Yes No

Part IV

Escrow and Custodial Arrangements. Complete if the organization answered "Yes" to Form 990,
Part IV, line 9, or reported an amount on Form 990, Part X, line 21.

Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................

Yes No

If "Yes," explain the arrangement in Part XIII and complete the following table:


c	Beginning balance .................................	1c
d	Additions during the year ..............................	1d
e	Distributions during the year .............................	1e
f	Ending balance ...................................	1f

Did the organization include an amount on Form 990, Part X, line 21? .....................

Yes No

If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ........

Part V

Endowment Funds. Complete if the organization answered "Yes" to Form 990, Part IV, line 10.

		(a)Current year	(b)Prior year	b (c)Two years back	(d)Three years back	(e)Four years back
1a	Beginning of year balance ....	87,204,664	89,724,541	86,399,272	60,472,244	60,355,993
b	Contributions ........	746,394	2,692,680	1,269,332	29,640,100	736,023
c	Net investment earnings, gains, and losses	5,114,694	3,521,682	6,139,492	1,622,561	4,138,384
d	Grants or scholarships .....
e	Other expenditures for facilities and programs ........	12,790,648	7,238,556	2,803,513	4,005,052	3,579,845
f	Administrative expenses ....	1,763,453	1,495,683	1,280,042	1,330,581	1,178,311
g	End of year balance ......	78,511,651	87,204,664	89,724,541	86,399,272	60,472,244

Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:

Board designated or quasi-endowment SchDMd Bullet

6.240 %

Permanent endowment SchDMd Bullet

66.520 %

Temporarily restricted endowment SchDMd Bullet

27.240 %

The percentages in lines 2a, 2b, and 2c should equal 100%.

Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes

(i) unrelated organizations ........................

3a(i)

(ii) related organizations ........................

3a(ii)

Yes

If "Yes" to 3a(ii), are the related organizations listed as required on Schedule R? .........

Yes

Describe in Part XIII the intended uses of the organization's endowment funds.

Part VI

Land, Buildings, and Equipment. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11a. See Form 990, Part X, line 10.

Description of property		(b)Cost or other basis (other)	(c) Accumulated depreciation	(d) Book value
1a	Land .................	535,324		535,324
b	Buildings ................	178,463,262	113,430,398	65,032,864
c	Leasehold improvements ............	15,196,931	2,064,793	13,132,138
d	Equipment ................	184,024,402	140,236,698	43,787,704
e	Other .................	12,904,071	44,773	12,859,298
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).).......				135,347,328

Schedule D (Form 990) 2013

Page 3

Part VII

InvestmentsOther Securities. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11b. See Form 990, Part X, line 12.

(a) Description of security or category (including name of security)		(b)Book value	(c) Method of valuation: Cost or end-of-year market value
(1)Financial derivatives
(2)Closely-held equity interests
Other








Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)

Part VIII

InvestmentsProgram Related. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11c. See Form 990, Part X, line 13.

(a) Description of investment		(b) Book value	(c) Method of valuation: Cost or end-of-year market value









Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)

Part IX

Other Assets. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11d. See Form 990, Part X, line 15.

(a) Description				(b) Book value
(1) DUE FROM AFFILIATES				23,365,037
(2) FUNDS HELD FOR RESEARCH				476,269
(3) CONSTRUCTION FUND				3,671,296
(4) DEBT SERVICE FUND				99,436
(5) SPECIAL CASH & CAPITAL RESERVE				3,812,308
(6) DEBT SERVICE RESERVES FUND				6,443,827
(7) DEFERRED FINANCING COSTS				1,452,248
(8) TAX DEFERRED PLAN				1,381,623
(9) CRICO				2,089,293
(10) QLT				7,171
Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........				42,798,508

Part X

Other Liabilities. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.

1.(a) Description of liability		(b) Book value
Federal income taxes		0
DUE TO AFFILIATES		117,211
ESTIMATE THIRD PARTY SETTLEMEN		3,912,860
PROFESSIONAL LIABILITY RESERVE		2,608,676
TAX DEFERRED LIABILITY		1,381,623





Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)		8,020,370
2. Liability for uncertain tax positions In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII ..................................................

Schedule D (Form 990) 2013

Page 4

Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return Complete if the organization answered 'Yes' to Form 990, Part IV, line 12a.
1	Total revenue, gains, and other support per audited financial statements .......		1
2	Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a	Net unrealized gains on investments ..........	2a
b	Donated services and use of facilities .........	2b
c	Recoveries of prior year grants ...........	2c
d	Other (Describe in Part XIII.) ............	2d
e	Add lines 2a through 2d .....................		2e
3	Subtract line 2e from line 1.....................		3
4	Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b .	4a
b	Other (Describe in Part XIII.) ...........	4b
c	Add lines 4a and 4b.......................		4c
5	Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ......		5

Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' to Form 990, Part IV, line 12a.
1	Total expenses and losses per audited financial statements ...........		1
2	Amounts included on line 1 but not on Form 990, Part IX, line 25:
a	Donated services and use of facilities ..........	2a
b	Prior year adjustments ..............	2b
c	Other losses ................	2c
d	Other (Describe in Part XIII.) ............	2d
e	Add lines 2a through 2d......................		2e
3	Subtract line 2e from line 1.....................		3
4	Amounts included on Form 990, Part IX, line 25, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b ..	4a
b	Other (Describe in Part XIII.) ............	4b
c	Add lines 4a and 4b.......................		4c
5	Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ......		5

Part XIII

Supplemental Information

Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b;
Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.

Return Reference	Explanation
SCHEDULE D, PART III, LINE 4:	THE RARE BOOKS COLLECTION CONSISTS MAINLY OF SEVERAL HUNDRED BOOKS IN THE MEEI specialties of ophthalmology and otolaryngology as well as a few on the medical history of Boston and Massachusetts. The majority were donated originally by Moses Lurie, MD and Mrs. Lucien Howe (wife of Lucien Howe, MD). A few were donated by other physicians through the years. Endowment funds set up between Mrs. Howe and Dr. Lurie were designated for the occasional purchase of rare books to supplement the original donations. The rare books are available to the scientific, medical and academic community for purposes of research and education. SCHEDULE D, PART V, LINE 4: THE ENDOWMENT FUNCTIONS TO SUPPORT THE MISSION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY TO PROVIDE SUPERIOR PATIENT CARE AND RESEARCH. THE INCOME FROM THE ENDOWMENT FUNDS ARE SUBJECT TO DONOR-IMPOSED STIPULATIONS USUALLY FOR RESEARCH, EDUCATION AND PATIENT CARE.
SCHEDULE D, PART X, LINE 2:	THE MASSACHUSETTS EYE AND EAR INFIRMARY ("INFIRMARY") WAS INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS WITH ITS AFFILIATED ORGANIZATIONS. THE INCOME TAX FOOTNOTE IS AS FOLLOWS: THE FOUNDATION AND ITS AFFILIATES QUALIFY AS TAX-EXEMPT ORGANIZATIONS UNDER THE INTERNAL REVENUE CODE. THE FOUNDATION, INFIRMARY, ASSOCIATES, SCHEPENS AND EMBANKMENT ARE TAX-EXEMPT UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND CIRCLE IS TAX-EXEMPT UNDER 501(C)(25) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN MADE IN THE ACCOMPANYING FINANCIAL STATEMENTS. MANAGEMENT HAS EVALUATED ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES AND THERE WAS NO IMPACT TO THE FOUNDATION'S FINANCIAL STATEMENTS FOR THE YEAR ENDED SEPTEMBER 30, 2014.

Return Reference

Explanation

SCHEDULE D, PART III, LINE 4:

THE RARE BOOKS COLLECTION CONSISTS MAINLY OF SEVERAL HUNDRED BOOKS IN THE MEEI specialties of ophthalmology and otolaryngology as well as a few on the medical history of Boston and Massachusetts. The majority were donated originally by Moses Lurie, MD and Mrs. Lucien Howe (wife of Lucien Howe, MD). A few were donated by other physicians through the years. Endowment funds set up between Mrs. Howe and Dr. Lurie were designated for the occasional purchase of rare books to supplement the original donations. The rare books are available to the scientific, medical and academic community for purposes of research and education. SCHEDULE D, PART V, LINE 4: THE ENDOWMENT FUNCTIONS TO SUPPORT THE MISSION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY TO PROVIDE SUPERIOR PATIENT CARE AND RESEARCH. THE INCOME FROM THE ENDOWMENT FUNDS ARE SUBJECT TO DONOR-IMPOSED STIPULATIONS USUALLY FOR RESEARCH, EDUCATION AND PATIENT CARE.

SCHEDULE D, PART X, LINE 2:

THE MASSACHUSETTS EYE AND EAR INFIRMARY ("INFIRMARY") WAS INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS WITH ITS AFFILIATED ORGANIZATIONS. THE INCOME TAX FOOTNOTE IS AS FOLLOWS: THE FOUNDATION AND ITS AFFILIATES QUALIFY AS TAX-EXEMPT ORGANIZATIONS UNDER THE INTERNAL REVENUE CODE. THE FOUNDATION, INFIRMARY, ASSOCIATES, SCHEPENS AND EMBANKMENT ARE TAX-EXEMPT UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND CIRCLE IS TAX-EXEMPT UNDER 501(C)(25) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN MADE IN THE ACCOMPANYING FINANCIAL STATEMENTS. MANAGEMENT HAS EVALUATED ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES AND THERE WAS NO IMPACT TO THE FOUNDATION'S FINANCIAL STATEMENTS FOR THE YEAR ENDED SEPTEMBER 30, 2014.

Schedule D (Form 990) 2013

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE F(Form 990)

Department of the Treasury
Internal Revenue Service

Statement of Activities Outside the United States

Complete if the organization answered "Yes" to Form 990,Part IV, line 14b, 15, or 16. Right pointing arrow large image

Attach to Form 990. Right pointing arrow large image

See separate instructions. Right pointing arrow large image

Information about Schedule F (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public Inspection

Name of the organization
MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

General Information on Activities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 14b.

For grantmakers.Does the organization maintain records to substantiate the amount of its grants and

other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used

to award the grants or assistance? ...............................

Yes

For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.

Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)

(a) Region		(d) Activities conducted in region (by type) (e.g., fundraising, program services, investments, grants to recipients located in the region)	(e) If activity listed in (d) is a program service, describe specific type of service(s) in region	(f) Total expenditures for and investments in region
	Europe (Including Iceland and Greenland)	Program Services	Conference	108,169
	South America	Program Services	Conference	15,286
	North America	Program Services	Conference	5,827
	South Asia	Program Services	Conference	2,100
	Central America and the Caribbean	Program Services	Conference	5,446
	East Asia and the Pacific	Program Services	Conference	10,536
	Central America and the Caribbean	Investments		24,200
	North America	Program Services	Research	64,739









3a	Sub-total .....			236,303
b	Total from continuation sheets to Part I ...
c	Totals (add lines 3a and 3b)			236,303

For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2013

Schedule F (Form 990) 2013

Page 2

Part II

Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.

(c) Region	(d) Purpose of grant	(e) Amount of cash grant	(f) Manner of cash disbursement	(g) Amount of non-cash assistance
North America	RESEARCH	64,739	Check	0

Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .... MediumBullet

Enter total number of other organizations or entities ....................... MediumBullet

Schedule F (Form 990) 2013

Schedule F (Form 990) 2013Page 3

Part III

Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 16.

Part III can be duplicated if additional space is needed.

(a) Type of grant or assistance		(b) Region	(c) Number of recipients	(d) Amount of cash grant	(e) Manner of cash disbursement	(f) Amount of non-cash assistance	(g) Description of non-cash assistance	(h) Method of valuation (book, FMV, appraisal, other)

Schedule F (Form 990) 2013

Page 4

Part IV

Foreign Forms

Schedule F (Form 990) 2013

Page 5

Part V

Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information (see instructions).

ReturnReference	Explanation
SCHEDULE F, PART I, LINE 2:	SUBRECIPIENT MONITORING POLICY AND PROCEDURES Part I Subawards are issued through a consortium agreement between the Massachusetts Eye and Ear Infirmary ("MEEI") and the recipient institution. The agreement specifies the terms of the subaward, and includes a detailed budget and scope of work to be performed by the recipient institution. Awarded funds are encumbered by a purchase order that is assigned to a unique fund number. Payments to recipient institutions made against the purchase order are recorded in the MEEI accounting system so that individual payments and purchase order balances can be monitored. Disbursement of funds for subawards require the written approval of the Principal Investigator("PI"). Frequent progress reports and other forms of communication are required between the PI and the subrecipient institute to ensure that the scope of work is progressing at a satisfactory pace. Research Administration also conducts an annual inventory of institutions to which reserach has been subawarded. A risk assessment matrix is employed, along with a review of the subrecipients most recent A133 audit report, to determine the level of risk regarding the subrecipients ability to comply with federal guidelines.
SCHEDULE F, PART I, LINE 3, COLUMN(F) AND PART II, LINE 1:	THE INFIRMARY USES THE ACCRUAL METHOD OF ACCOUNTING AND SEPARATELY IDENTIFIES FOREIGN ACTIVITY ON ITS GENERAL LEDGER.

Schedule F (Form 990) 2013

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE G (Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Supplemental Information Regarding
Fundraising or Gaming Activities

Complete if the organization answered "Yes" to Form 990, Part IV, lines 17, 18, or 19, or if the organization entered more than $15,000 on Form 990-EZ, line 6a. right arrow

Attach to Form 990 or Form 990-EZ. right arrow

See separate instructions.
right arrow

Information about Schedule G (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public Inspection

Name of the organization
MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Fundraising Activities. Complete if the organization answered "Yes" to Form 990, Part IV, line 17.

Form 990-EZ filers are not required to complete this part.

Indicate whether the organization raised funds through any of the following activities. Check all that apply.

a	Mail solicitations	e	Solicitation of non-government grants
b	Internet and email solicitations	f	Solicitation of government grants
c	Phone solicitations	g	Special fundraising events
d	In-person solicitations

Did the organization have a written or oral agreement with any individual (including officers, directors, trustees

or key employees listed in Form 990, Part VII) or entity in connection with professional fundraising services?

Yes

If "Yes," list the ten highest paid individuals or entities (fundraisers) pursuant to agreements under which the fundraiser is
to be compensated at least $5,000 by the organization.

(i) Name and address of individual or entity (fundraiser)		(ii) Activity	(iii) Did fundraiser have custody or control of contributions?		(v) Amount paid to (or retained by) fundraiser listed in col. (i)
			Yes	No
	VISION PHILANTHROPY GROUP	CAPITAL CAMPAIGN		No	115,069
	HUNTSINGER JEFFER INC	ANNUAL FUND		No	63,000








Total .................					178,069

List all states in which the organization is registered or licensed to solicit contributions or has been notified it is exempt from registration or licensing.

ME, MA, NY

For Paperwork Reduction Act Notice, see the Instructions for Form 990or 990-EZ.

Cat. No. 50083H

Schedule G (Form 990 or 990-EZ) 2013

Page 2

Part II

Fundraising Events. Complete if the organization answered "Yes" to Form 990, Part IV, line 18, or reported more than $15,000 of fundraising event contributions and gross income on Form 990-EZ, lines 1 and 6b. List events with gross receipts greater than $5,000.

			(a) Event #1 (event type)	(b) Event #2 (event type)	(c) Other events (total number)	(d) Total events (add col. (a) through col. (c))
	1	Gross receipts . . .
	2	Less: Contributions . .
	3	Gross income (line 1 minus line 2) . . .
	4	Cash prizes . . .
	5	Noncash prizes . .
	6	Rent/facility costs . .
	7	Food and beverages .
	8	Entertainment . . .
	9	Other direct expenses .
	10	Direct expense summary. Add lines 4 through 9 in column (d) ...........
	11	Net income summary. Subtract line 10 from line 3, column (d)...........

Part III

Gaming. Complete if the organization answered "Yes" to Form 990, Part IV, line 19, or reported more than $15,000 on Form 990-EZ, line 6a.

(a) Bingo

(b) Pull tabs/Instant
bingo/progressive bingo

(c) Other gaming

(d) Total gaming (add col.(a) through col.(c))

Gross revenue . . . .

Cash prizes . . . .

Non-cash prizes . . .

Rent/facility costs . . .

Other direct expenses . .

Volunteer labor . . .

	Yes %
	No

	Yes %
	No

	Yes %
	No

Direct expense summary. Add lines 2 through 5 in column (d) ........... right arrow

Net gaming income summary. Subtract line 7 from line 1, column (d) ......... right arrow

Enter the state(s) in which the organization operates gaming activities:

Is the organization licensed to operate gaming activities in each of these states? ............

YesNo

If "No," explain:

10a

Were any of the organization's gaming licenses revoked, suspended or terminated during the tax year? .....

YesNo

If "Yes," explain:

Schedule G (Form 990 or 990-EZ) 2013

Page 3

Does the organization operate gaming activities with nonmembers? .................

YesNo

Is the organization a grantor, beneficiary or trustee of a trust or a member of a partnership or other entity

formed to administer charitable gaming? ..........................

YesNo

Indicate the percentage of gaming activity operated in:

The organization's facility ......................

13a

An outside facility ........................

13b

Enter the name and address of the person who prepares the organization's gaming/special events books and records:

Name

Address

15a

Does the organization have a contract with a third party from whom the organization receives gaming

revenue? ......................................

YesNo

If "Yes," enter the amount of gaming revenue received by the organization right arrow

$ and the

amount of gaming revenue retained by the third party right arrow

$ .

If "Yes," enter name and address of the third party:

Name

Address

Gaming manager information:

Name

Gaming manager compensation right arrow

Description of services provided right arrow

Director/officer Employee Independent contractor

Mandatory distributions:

Is the organization required under state law to make charitable distributions from the gaming proceeds to

retain the state gaming license? ............................

YesNo

Enter the amount of distributions required under state law distributed to other exempt organizations or spent

in the organization's own exempt activities during the tax year right arrow

Part IV

Supplemental Information. Provide the explanations required by Part I, line 2b, columns (iii) and (v), and Part III, lines 9, 9b, 10b, 15b, 15c, 16, and 17b, as applicable. Also complete this part to provide any additional information (see instructions).

Return Reference	Explanation
DURING THE FISCAL YEAR ENDED SEPTEMBER 20, 2014, THE MASSACHUSETTS EYE	AND EAR INFIRMARY ("THE INFIRMARY") CONTRACTED WITH HUNTSINGER & JEFFER, A FUNDRAISING CONSULTING COMPANY, TO ASSIST WITH THE FOUNDATION'S MAILING CAMPAIGN BY DRAFTING LETTERS AND WORKING WITH A MAIL HOUSE TO SEND LETTERS AND EMAILS TO PATIENTS ON THE INFIRMARY'S BEHALF. THE INFIRMARY ALSO CONTRACTED WITH VISION PHILANTHROPY TO ASSIST WITH THE INFIRMARY'S CAPITAL FUNDRAISING CAMPAIGN.

Schedule G (Form 990 or 990-EZ) 2013

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE H (Form 990)

Department of the Treasury
Internal Revenue Service

Hospitals

Complete if the organization answered "Yes" to Form 990, Part IV, question 20.
MediumBullet

Attach to Form 990. MediumBullet

See separate instructions.
MediumBullet

Information about Schedule H (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Financial Assistance and Certain Other Community Benefits at Cost

Yes

Did the organization have a financial assistance policy during the tax year? If "No," skip to question 6a ...

Yes

If "Yes," was it a written policy? .......................

Yes

If the organization had multiple hospital facilities, indicate which of the following best describes application of the financial assistance policy to its various hospital facilities during the tax year.

Applied uniformly to all hospital facilities Applied uniformly to most hospital facilities Generally tailored to individual hospital facilities

Answer the following based on the financial assistance eligibility criteria that applied to the largest number of the organization's patients during the tax year.

Did the organization use Federal Poverty Guidelines (FPG) as a factor in determining eligibility for providing free care?

If "Yes," indicate which of the following was the FPG family income limit for eligibility for free care:

Yes

100% 150% 200% Other 400 %

Did the organization use FPG as a factor in determining eligibility for providing discounted care? If "Yes," indicate

which of the following was the family income limit for eligibility for discounted care: .........

Yes

200% 250% 300% 350% 400% Other %

If the organization used factors other than FPG in determining eligibility, describe in Part VI the income based criteria for determining eligibility for free or discounted care. Include in the description whether the organization used an asset test or other threshold, regardless of income, as a factor in determining eligibility for free or discounted care.

Did the organization's financial assistance policy that applied to the largest number of its patients during the tax year provide for free or discounted care to the "medically indigent"? ..............

Yes

Did the organization budget amounts for free or discounted care provided under its financial assistance policy during the tax year? ............................

Yes

If "Yes," did the organization's financial assistance expenses exceed the budgeted amount? ......

Yes

If "Yes" to line 5b, as a result of budget considerations, was the organization unable to provide free or discountedcare to a patient who was eligibile for free or discounted care? ..............

Did the organization prepare a community benefit report during the tax year? ..........

Yes

If "Yes," did the organization make it available to the public? ..............

Yes

Complete the following table using the worksheets provided in the Schedule H instructions. Do not submit these worksheets with the Schedule H.

Financial Assistance and Certain Other Community Benefits at Cost

Financial Assistance and Means-Tested Government Programs		(a) Number of activities or programs (optional)	(b) Persons served (optional)	(c) Total community benefit expense	(d) Direct offsetting revenue	(e) Net community benefit expense	(f) Percent of total expense
a	Financial Assistance at cost (from Worksheet 1) ..			3,373,958	3,116,930	257,028	0.110 %
b	Medicaid (from Worksheet 3, column a) ....			14,881,590	11,934,256	2,947,334	1.290 %
c	Costs of other means-tested government programs (from Worksheet 3, column b) .			3,362,490	2,044,201	1,318,289	0.580 %
d	Total Financial Assistance and Means-Tested Government Programs .			21,618,038	17,095,387	4,522,651	1.980 %
Other Benefits				509,635		509,635	0.220 %
e	Community health improvement services and community benefit operations (from Worksheet 4) ..			509,635		509,635	0.220 %
f	Health professions education (from Worksheet 5) ..			8,165,803	1,460,256	6,705,547	2.940 %
g	Subsidized health services (from Worksheet 6) ..	2	665	1,486,292	1,186,068	300,224	0.130 %
h	Research (from Worksheet 7)			41,823,183	34,809,269	7,113,914	3.120 %
i	Cash and in-kind contributions for community benefit (from Worksheet 8)			34,300		34,300	0.020 %
j	Total. Other Benefits ..	2	665	52,019,213	37,455,593	14,663,620	6.430 %
k	Total. Add lines 7d and 7j .	2	665	73,637,251	54,550,980	19,186,271	8.410 %

For Paperwork Reduction Act Notice, see the Instructions for Form 990. Cat. No. 50192T Schedule H (Form 990) 2013

Schedule H (Form 990) 2013

Page

Part II

Community Building Activities Complete this table if the organization conducted any community building activities during the tax year, and describe in Part VI how its community building activities promoted the health of the communities it serves.

		(a) Number of activities or programs (optional)	(b) Persons served (optional)	(c) Total community building expense	(d) Direct offsetting revenue	(e) Net community building expense	(f) Percent of total expense
1	Physical improvements and housing
2	Economic development
3	Community support
4	Environmental improvements
5	Leadership development and training for community members
6	Coalition building
7	Community health improvement advocacy
8	Workforce development
9	Other
10	Total

Part III

Bad Debt, Medicare, & Collection Practices

Section A. Bad Debt Expense

Yes

Did the organization report bad debt expense in accordance with Heathcare Financial Management Association Statement No. 15? ..........................

Yes

Enter the amount of the organization's bad debt expense. Explain in Part VI the methodology used by the organization to estimate this amount. ......

2,461,675

Enter the estimated amount of the organization's bad debt expense attributable to patients eligible under the organization's financial assistance policy. Explain in Part VI the methodology used by the organization to estimate this amount and the rationale, if any, for including this portion of bad debt as community benefit. ......

9,916

Provide in Part VI the text of the footnote to the organization’s financial statements that describes bad debt expense or the page number on which this footnote is contained in the attached financial statements.

Section B. Medicare

Enter total revenue received from Medicare (including DSH and IME).....

43,526,177

Enter Medicare allowable costs of care relating to payments on line 5.....

46,714,922

Subtract line 6 from line 5. This is the surplus (or shortfall)........

-3,188,745

Describe in Part VI the extent to which any shortfall reported in line 7 should be treated as community benefit.Also describe in Part VI the costing methodology or source used to determine the amount reported on line 6.Check the box that describes the method used:

Cost accounting system Cost to charge ratio Other

Section C. Collection Practices

Did the organization have a written debt collection policy during the tax year? ..........

Yes

If "Yes," did the organization’s collection policy that applied to the largest number of its patients during the tax year contain provisions on the collection practices to be followed for patients who are known to qualify for financial assistance? Describe in Part VI.......................

Yes

Part IV

Management Companies and Joint Ventures(owned 10% or more by officers, directors, trustees, key employees, and physicians—see instructions)

(a) Name of entity	(b) Description of primary activity of entity	(c) Organization's profit % or stock ownership %	(d) Officers, directors, trustees, or key employees' profit % or stock ownership %	(e) Physicians' profit % or stock ownership %
1
2
3
4
5
6
7
8
9
10
11
12
13

Schedule H (Form 990) 2013

Page

Part VFacility Information

Section A. Hospital Facilities (list in order of size from largest to smallest—see instructions) How many hospital facilities did the organization operate during the tax year?1 Name, address, primary website address, and state license number
1	MASSACHUSETTS EYE & EAR INFIRMARY 243 CHARLES STREET BOSTON,MA02114 http://www.masseyeandear.org/ 2167	X	X	X	X

Schedule H (Form 990) 2013

Page

Part VFacility Information (continued)

Section B. Facility Policies and Practices

(Complete a separate Section B for each of the hospital facilities or facility reporting groups listed in Part V, Section A)

	MASSACHUSETTS EYE & EAR INFIRMARY
Name of hospital facility or facility reporting group

If reporting on Part V, Section B for a single hospital facility only: line number of
hospital facility (from Schedule H, Part V, Section A)

Yes

Community Health Needs Assessment (Lines 1 through 8c are optional for tax years begining on or before March 23, 2012)

During the tax year or either of the two immediately preceding tax years, did the hospital facility conduct a community health needs assessment (CHNA)? If "No," skip to line 9....................

Yes

If "Yes," indicate what the CHNA report describes (check all that apply):

A definition of the community served by the hospital facility

Demographics of the community

Existing health care facilities and resources within the community that are available to respond to the health needs of the community

How data was obtained

The health needs of the community

Primary and chronic disease needs and other health issues of uninsured persons, low-income persons, and minority groups

The process for identifying and prioritizing community health needs and services to meet the community health needs

The process for consulting with persons representing the community’s interests

Information gaps that limit the hospital facility’s ability to assess the community’s health needs

Other (describe in Part VI)

Indicate the tax year the hospital facility last conducted a CHNA: 20 13

In conducting its most recent CHNA, did the hospital facility take into account input from persons who represent the broad interests of the community served by the hospital facility, including those with special knowledge of or expertise in public health? If "Yes," describe in Part VI how the hospital facility took into account input from persons who represent the community, and identify the persons the hospital facility consulted ....................

Yes

Was the hospital facility’s CHNA conducted with one or more other hospital facilities? If "Yes," list the other hospital facilities in Part VI................................

Did the hospital facility make its CHNA report widely available to the public? .............

Yes

If "Yes," indicate how the CHNA report was made widely available (check all that apply):

Hospital facility’s website (list url): WWW.MASSEYEANDEAR.ORG

Other website (list url):

Available upon request from the hospital facility

Other (describe in Part VI)

If the hospital facility addressed needs identified in its most recently conducted CHNA, indicate how (check all that apply as of the end of the tax year):

Adoption of an implementation strategy that addresses each of the community health needs identified through the CHNA

Execution of the implementation strategy

Participation in the development of a community-wide plan

Participation in the execution of a community-wide plan

Inclusion of a community benefit section in operational plans

Adoption of a budget for provision of services that address the needs identified in the CHNA

Prioritization of health needs in its community

Prioritization of services that the hospital facility will undertake to meet health needs in its community

Other (describe in Part VI)

Did the hospital facility address all of the needs identified in its most recently conducted CHNA? If "No," explain in Part VI which needs it has not addressed and the reasons why it has not addressed such needs ........

Did the organization incur an excise tax under section 4959 for the hospital facility's failure to conduct a CHNA as required by section 501(r)(3)? ...........................

If "Yes" to line 8a, did the organization file Form 4720 to report the section 4959 excise tax? ......

If "Yes" to line 8b, what is the total amount of section 4959 excise tax the organization reported on Form 4720 for all of its hospital facilities? $

Schedule H (Form 990) 2013

Page

Part VFacility Information (continued)

Financial Assistance Policy			Yes	No
9	Did the hospital facility have in place during the tax year a written financial assistance policy that:
	Explained eligibility criteria for financial assistance, and whether such assistance includes free or discounted care?	9	Yes
10	Used federal poverty guidelines (FPG) to determine eligibility for providing free care?...........	10	Yes
	If "Yes," indicate the FPG family income limit for eligibility for free care: 400.% If "No," explain in Part VI the criteria the hospital facility used.
11	Used FPG to determine eligibility for providing discounted care?.................	11	Yes
	If "Yes," indicate the FPG family income limit for eligibility for discounted care: 400.% If "No," explain in Part VI the criteria the hospital facility used.
12	Explained the basis for calculating amounts charged to patients?.................	12	Yes
	If "Yes," indicate the factors used in determining such amounts (check all that apply):
a	Income level
b	Asset level
c	Medical indigency
d	Insurance status
e	Uninsured discount
f	Medicaid/Medicare
g	State regulation
h	Residency
i	Other (describe in Part VI)
13	Explained the method for applying for financial assistance?...................	13	Yes
14	Included measures to publicize the policy within the community served by the hospital facility?.......	14	Yes
	If "Yes," indicate how the hospital facility publicized the policy (check all that apply):
a	The policy was posted on the hospital facility’s website
b	The policy was attached to billing invoices
c	The policy was posted in the hospital facility’s emergency rooms or waiting rooms
d	The policy was posted in the hospital facility’s admissions offices
e	The policy was provided, in writing, to patients on admission to the hospital facility
f	The policy was available upon request
g	Other (describe in Part VI)
Billing and Collections
15	Did the hospital facility have in place during the tax year a separate billing and collections policy, or a written financial assistance policy (FAP) that explained actions the hospital facility may take upon non-payment?.......	15	Yes
16	Check all of the following actions against an individual that were permitted under the hospital facility's policies during the tax year before making reasonable efforts to determine the individual’s eligibility under the facility’s FAP:
a	Reporting to credit agency
b	Lawsuits
c	Liens on residences
d	Body attachments
e	Other similar actions (describe in Section C)
17	Did the hospital facility or an authorized third party perform any of the following actions during the tax year before making reasonable efforts to determine the individual’s eligibility under the facility’s FAP?..........	17		No
	If "Yes," check all actions in which the hospital facility or a third party engaged:
a	Reporting to credit agency
b	Lawsuits
c	Liens on residences
d	Body attachments
e	Other similar actions (describe in Section C)

Schedule H (Form 990) 2013

Page

Part VFacility Information (continued)

Indicate which efforts the hospital facility made before initiating any of the actions listed in line 17 (check all that apply):

Notified individuals of the financial assistance policy on admission

Notified individuals of the financial assistance policy prior to discharge

Notified individuals of the financial assistance policy in communications with the individuals regarding the individuals’ bills

Documented its determination of whether individuals were eligible for financial assistance under the hospital facility’s financial assistance policy

Other (describe in Section C)

Policy Relating to Emergency Medical Care

Yes

Did the hospital facility have in place during the tax year a written policy relating to emergency medical care that requires the hospital facility to provide, without discrimination, care for emergency medical conditions to individuals regardless of their eligibility under the hospital facility’s financial assistance policy?..........

Yes

If "No," indicate why:

The hospital facility did not provide care for any emergency medical conditions

The hospital facility’s policy was not in writing

The hospital facility limited who was eligible to receive care for emergency medical conditions (describe in Part VI)

Other (describe in Part VI)

Charges to Individuals Eligible for Assistance under the FAP (FAP-Eligible Individuals)

Indicate how the hospital facility determined, during the tax year, the maximum amounts that can be charged to FAP-eligible individuals for emergency or other medically necessary care.

The hospital facility used its lowest negotiated commercial insurance rate when calculating the maximum amounts that can be charged

The hospital facility used the average of its three lowest negotiated commercial insurance rates when calculating the maximum amounts that can be charged

The hospital facility used the Medicare rates when calculating the maximum amounts that can be charged

Other (describe in Part VI)

During the tax year, did the hospital facility charge any FAP-eligible individual to whom the hospital facility provided emergency or other medically necessary services more than the amounts generally billed to individuals who had insurance covering such care? ............................

If "Yes," explain in Part VI.

During the tax year, did the hospital facility charge any FAP-eligible individual an amount equal to the gross charge for any service provided to that individual? .........................

If "Yes," explain in Part VI.

Schedule H (Form 990) 2013

Page

Part V

Facility Information (continued)

Section C. Supplemental Information for Part V, Section B.Provide descriptions required for Part V, Section B, lines 1j, 3, 4, 5d, 6i, 7, 10, 11, 12i, 14g, 16e, 17e, 18e, 19c, 19d, 20d, 21, and 22. If applicable, provide separate descriptions for each facility in a facility reporting group, designated by "Facility A," "Facility B," etc.
Form and Line Reference	Explanation
schedule h, part v, section b, line 3:	To gain a better understanding of needs in Mission Hill specifically, the consultants worked with the Mass. Eye and Ear CB Working Group and with Brigham and Women's Hospital Community Benefits leaders to identify Mission Hill service providers, advocates and educators positioned to speak to the needs of the community. The consultants then conducted ten in-depth interviews with the identified key informants. (See Figure 12 in the official MEEI Community Benefits Report for the key informant interview participants and their organizational affiliations.) Among them was a member of the New England Baptist Hospital, which operates a smaller but highly regarded community benefits program targeting Mission Hill. The experiences of the BWH and New England Baptist provided great insights that informed the assessment and planning processes described below. The interviews yielded important and useful information about neighborhood characteristics, methods for building and sustaining strong relationships in Mission Hill, the needs of the neighborhood, and partnership opportunities. Schedule H, Part V, Section B, Line 6a: The implementation strategy can be found within the community health needs assessment online at the MEEI website, www.masseyeandear.org. Schedule H, Part V, Section B, Line 7: Mass. Eye and Ear's strategies proved successful at achieving our annual targets and supporting our community benefits objectives. The CHNA includes tables that display the expected outcomes/targets established for the year and describe our progress in meeting those targets. In most cases, targets were either met or exceeded. In cases in which targets were not been met, information is provided to explain why our progress fell short of the targets and to describe our quality improvement plans, if needed, to ensure that we are able to meet our targets moving forward. Targets Missed: -At least 50 young adults will received comprehensive eye exams. Only 35 young adults receive exams through vision coalition. -Provide self-defense training to at least 10 individuals with blindness or vision impairment. None received training because group disbanded during the fiscal year. -At least 50 people will be screen for head/neck cancer. We allocated space for 50 patients but only 40 people were screened at the Head and Neck Cancer Screening/Table. -Mass. Eye and Ear patients who need assistance with lodging, food, and other vital necessities will receive help in securing those resources. Only 30 people received assistance securing resources. MEEI believes more people have access to the internet are handling these needs by themselves. We assisted all who requested assistance. -AT LEAST 2,500 PEOPLE WHO REQUIRE FREE PARKING WILL RECEIVE IT. ONLY 200 PEOPLE RECEIVED FREE PARKING. WE LOST CONTROL OF OUR PARKING LOT LEASE AND NO LONGER PROVIDE FREE PARKING TO SOME COMMUNITY GROUPS. WE WILL ADJUST TARGET FOR NEXT YEAR SINCE WE DO NOT HAVE CONTROL OVER THE LOTS ANYMORE. SCHEDULE H, PART V, SECTION B, LINE 20D: CHARGES FOR PATIENTS WHO QUALIFY FOR FINANCIAL ASSISTANCE ARE BASED ON THE AVERAGE REIMBURSEMENT OF THE INFIRMARY'S THREE LARGEST PAYERS.

Schedule H (Form 990) 2013

Page

Part VFacility Information (continued)

Section D. Other Health Care Facilities That Are Not Licensed, Registered, or Similarly Recognized as a Hospital Facility (list in order of size, from largest to smallest) How many non-hospital health care facilities did the organization operate during the tax year?9
Name and address		Type of Facility (describe)
1	MASSACHUSETTS EYE & EAR STONEHAM ONE MONTVALE AVENUE STONEHAM,MA02180	LICENSED OUTPATIENT LOCATION
2	MASSACHUSETTS EYE & EAR E BRIDGEWATER ONE COMPASS WAY SUITE 100 E BRIDGEWATER,MA02333	LICENSED OUTPATIENT LOCATION
3	MEEI VESTIBULAR CENTER AT BRAINTREE 250 POND STREET 1ST FLOOR BRAINTREE,MA02184	LICENSED OUTPATIENT LOCATION
4	MASSACHUSETTS EYE & EAR QUINCY 500 CONGRESS STREET QUINCY,MA02169	LICENSED OUTPATIENT LOCATION
5	MASSACHUSETTS EYE & EAR AT JOSLIN 1 JOSLIN PLACE BOSTON,MA02215	LICENSED OUTPATIENT LOCATION
6	MEE CONCORD SIGHT (AUDIOLOGY ONLY) 54 BAKER AVE EXTENSION 3RD FL STE CONCORD,MA01742	LICENSED OUTPATIENT LOCATION
7	MASSACHUSETTS EYE & EAR LONGWOOD 800 HUNTINGTON AVENUE BOSTON,MA02115	LICENSED OUTPATIENT LOCATION
8	MASSACHUSETTS EYE & EAR MEDFORD 101 MAIN STREET MEDFORD,MA02115	LICENSED OUTPATIENT LOCATION
9	MASSACHUSETTS EYE & EAR PLAINVILLE 30 MAN MAR DRIVE STE 2 PLAINVILLE,MA02762	LICENSED OUTPATIENT LOCATION
10

Schedule H (Form 990) 2013

Page

Part VI

Supplemental Information

Provide the following information.

1	Required descriptions. Provide the descriptions required for Part I, lines 3c, 6a, and 7; Part II and Part III, lines 2, 3, 4, 8 and 9b.
2	Needs assessment. Describe how the organization assesses the health care needs of the communities it serves, in addition to any CHNAs reported in Part V, Section B.
3	Patient education of eligibility for assistance. Describe how the organization informs and educates patients and persons who may be billed for patient care about their eligibility for assistance under federal, state, or local government programs or under the organization’s financial assistance policy.
4	Community information. Describe the community the organization serves, taking into account the geographic area and demographic constituents it serves.
5	Promotion of community health. Provide any other information important to describing how the organization’s hospital facilities or other health care facilities further its exempt purpose by promoting the health of the community (e.g., open medical staff, community board, use of surplus funds, etc.).
6	Affiliated health care system. If the organization is part of an affiliated health care system, describe the respective roles of the organization and its affiliates in promoting the health of the communities served.
7	State filing of community benefit report. If applicable, identify all states with which the organization, or a related organization, files a community benefit report.

Form and Line Reference

Explanation

schedule h, part v, section b, line 3:

To gain a better understanding of needs in Mission Hill specifically, the consultants worked with the Mass. Eye and Ear CB Working Group and with Brigham and Women's Hospital Community Benefits leaders to identify Mission Hill service providers, advocates and educators positioned to speak to the needs of the community. The consultants then conducted ten in-depth interviews with the identified key informants. (See Figure 12 in the official MEEI Community Benefits Report for the key informant interview participants and their organizational affiliations.) Among them was a member of the New England Baptist Hospital, which operates a smaller but highly regarded community benefits program targeting Mission Hill. The experiences of the BWH and New England Baptist provided great insights that informed the assessment and planning processes described below. The interviews yielded important and useful information about neighborhood characteristics, methods for building and sustaining strong relationships in Mission Hill, the needs of the neighborhood, and partnership opportunities. Schedule H, Part V, Section B, Line 6a: The implementation strategy can be found within the community health needs assessment online at the MEEI website, www.masseyeandear.org. Schedule H, Part V, Section B, Line 7: Mass. Eye and Ear's strategies proved successful at achieving our annual targets and supporting our community benefits objectives. The CHNA includes tables that display the expected outcomes/targets established for the year and describe our progress in meeting those targets. In most cases, targets were either met or exceeded. In cases in which targets were not been met, information is provided to explain why our progress fell short of the targets and to describe our quality improvement plans, if needed, to ensure that we are able to meet our targets moving forward. Targets Missed: -At least 50 young adults will received comprehensive eye exams. Only 35 young adults receive exams through vision coalition. -Provide self-defense training to at least 10 individuals with blindness or vision impairment. None received training because group disbanded during the fiscal year. -At least 50 people will be screen for head/neck cancer. We allocated space for 50 patients but only 40 people were screened at the Head and Neck Cancer Screening/Table. -Mass. Eye and Ear patients who need assistance with lodging, food, and other vital necessities will receive help in securing those resources. Only 30 people received assistance securing resources. MEEI believes more people have access to the internet are handling these needs by themselves. We assisted all who requested assistance. -AT LEAST 2,500 PEOPLE WHO REQUIRE FREE PARKING WILL RECEIVE IT. ONLY 200 PEOPLE RECEIVED FREE PARKING. WE LOST CONTROL OF OUR PARKING LOT LEASE AND NO LONGER PROVIDE FREE PARKING TO SOME COMMUNITY GROUPS. WE WILL ADJUST TARGET FOR NEXT YEAR SINCE WE DO NOT HAVE CONTROL OVER THE LOTS ANYMORE. SCHEDULE H, PART V, SECTION B, LINE 20D: CHARGES FOR PATIENTS WHO QUALIFY FOR FINANCIAL ASSISTANCE ARE BASED ON THE AVERAGE REIMBURSEMENT OF THE INFIRMARY'S THREE LARGEST PAYERS.

Schedule H (Form 990) 2013

Additional Data

Software ID:
Software Version:

- TIN:

Schedule I
(Form 990)

Department of the Treasury
Internal Revenue Service

Grants and Other Assistance to Organizations,
Governments and Individuals in the United States

Complete if the organization answered "Yes," to Form 990, Part IV, line 21 or 22.
lBullet

Attach to Form 990
lBullet

Information about Schedule I (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public
Inspection

Name of the organization
MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number
04-2103591

Part I

General Information on Grants and Assistance

Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ....................................

Yes No

Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.

Part II

Grants and Other Assistance to Governments and Organizations in the United States. Complete if the organization answered "Yes" to
Form 990, Part IV, line 21, for any recipient that received more than $5,000. Part II can be duplicated if additional space is needed.

(a) Name and address of organization or government	(b) EIN	(c) IRC Code section if applicable	(d) Amount of cash grant	(h) Purpose of grant or assistance
(1) BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVE BOSTON,MA02115	04-2774441	501(C)(3)	147,876	RESEARCH
(2) BOSTON UNIVERSITY 85 E NEWTON ST M-921 BOSTON,MA02118	04-2103547	501(C)(3)	60,551	RESEARCH
(3) BRIGHAM AND WOMEN'S HOSPITAL 75 FRANCIS ST BOSTON,MA02115	04-2312909	501(C)(3)	247,340	RESEARCH
(4) OHIO UNIVERSITY 1 PARK PLACE ATHENS,OH45701	31-6402113	501(C)(3)	49,618	RESEARCH
(5) JOHNS HOPKINS UNIVERSITY 600 N WOLF ST BALTIMORE,MD21218	52-0595110	501(C)(3)	10,496	RESEARCH
(6) MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT ST BOSTON,MA02114	04-2697983	501(C)(3)	577,841	RESEARCH
(7) MIT DIVISION OF HEALTH 77 MASS AVE CAMBRIDGE,MA02139	04-2103594	501(C)(3)	84,724	RESEARCH
(8) MAYO CLINIC 200 1ST ST SW ROCHESTER,MN55905	41-6011702	501(C)(3)	121,084	RESEARCH
(9) HARVARD UNIVERSITY MASS HALL CAMBRIDGE,MA02138	04-2103580	501(C)(3)	1,041,998	RESEARCH
(10) VANDERBILT MEDICAL CENTER 211 KIRKLAND HALL NASHVILLE,TN37240	62-0476822	501(C)(3)	25,111	RESEARCH
(11) WORCESTER POLYTECHNIC INSTITUTE 100 INSTITUTE RD WORCESTER,MA01609	04-2121659	501(C)(3)	124,482	RESEARCH
(12) SCHEPENS EYE RESEARCH INSTITUTE 20 STANIFORD ST BOSTON,MA02114	04-2129889	501(C)(3)	1,216,859	RESEARCH
(13) UNIVERSITY OF MIAMI 1400 NW 10TH AVE MIAMI,FL33136	59-0624458	501(C)(3)	156,552	RESEARCH
(14) BROAD INSTITUTE 7 CAMBRIDGE CENTER CAMBRIDGE,MA02142	26-3428781	501(C)(3)	8,389	RESEARCH
(15) MEDICAL COLLEGE OF WISCONSIN 8701 WATERTOWN PLANK RD MILWAUKEE,WI53226	39-0806261	501(C)(3)	49,196	RESEARCH
(16) DREXEL UNIVERSITY 3201 ARCH ST 100 PHILADELPHIA,PA19104	23-1352630	501(C)(3)	25,176	RESEARCH
(17) TUFTS UNIVERSITY 136 HARRISON AVE BOSTON,MA02111	04-2163634	501(C)(3)	9,632	RESEARCH
(18) MASSACHUSETTS EYE AND EAR ASSOCIATES INC 243 CHARLES STREET BOSTON,MA02114	22-2658209	501(C)(3)	12,247,673	INSTITUTIONAL
(19) RHODE ISLAND HOSPITAL 593 Eddy Street Providence,RI029034923	05-0258954	501(c)(3)	344,385	RESEARCH
(20) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SD 9500 Gilman Dr MC0934 San Diego,CA92023	95-6006144	115	28,618	RESEARCH
(21) JOAN&SANFORD IWEILL MEDICAL COLL OF CORNEL UNIV 1305 New York Ave New York,NY10065	15-0532082	501(c)(3)	83,301	RESEARCH
(22) MARSHFIELD CLINICAL RESEARCH FOUNDATION 1000 North Oak Avenue Marshfield,WI54449	39-0452970	501(c)(3)	7,932	RESEARCH
(23) SCHEPENS EYE RESEARCH INSTITUTE 20 STANIFORD ST BOSTON,MA02114	04-2129889	501(C)(3)	841,628	INSTITUTIONAL
(24) Chicago Association for Research and Education 5000 South 5th Avenue Hines,IL60141	36-3334177	501(C)(3)	161,402	RESEARCH
(25) Loyola University of Chicago 2160 S First Ave Maywood,IL60153	36-1408475	501(C)(3)	13,613	RESEARCH
(26) University of Michigan 500 S State St Ann Arbor,MI48109	38-6006309	115	18,023	RESEARCH

Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................ Bullet Image

Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50055P

Schedule I (Form 990) 2013

Page 2

Part III

Grants and Other Assistance to Individuals in the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.

(a)Type of grant or assistance	(b)Number of recipients	(c)Amount of cash grant	(d)Amount of non-cash assistance	(e)Method of valuation (book, FMV, appraisal, other)	(f)Description of non-cash assistance

Part IV

Supplemental Information. Provide the information required in Part I, line 2, Part III, column (b), and any other additional information.

Return Reference

Explanation

SCHEDULE I, PART I, LINE 2:

SUBRECIPIENT MONITORING POLICY AND PROCEDURES Part I. Subawards are issued through a consortium agreement between the Massachusetts Eye and Ear Infirmary ("MEEI") and the recipient institution. The agreement specifies the terms of the subaward, and includes a detailed budget and scope of work to be performed by the recipient institution. Awarded funds are encumbered by a purchase order that is assigned to a unique fund number. Payments to recipient institutions made against the purchase order are recorded in the MEEI accounting system so that individual payments and purchase order balances can be monitored. Disbursement of funds for subawards require the written approval of the Principal Investigator("PI"). Frequent progress reports and other forms of communication are required between the PI and the subrecipient institute to ensure that the scope of work is progressing at a satisfactory pace. Research Administration also conducts an annual inventory of institutions to which research has been sub awarded. A risk assessment matrix is employed, along with a review of the subrecepients most recent A133 audit report, to determine the level of risk regarding the sub recipient's ability to comply with federal guidelines.

Schedule I (Form 990) 2013

Additional Data

Software ID:
Software Version:

- TIN:

Schedule J
(Form 990)

Department of the Treasury
Internal Revenue Service

Compensation Information

For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet

Complete if the organization answered "Yes" to Form 990, Part IV, line 23.
SchJMediumBullet

Attach to Form 990. SchJMediumBullet

See separate instructions.
SchJMediumBullet

Information about Schedule J (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Questions Regarding Compensation

Yes

Check the appropiate box(es) if the organization provided any of the following to or for a person listed in Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.

First-class or charter travel Housing allowance or residence for personal use

Travel for companions Payments for business use of personal residence

Tax idemnification and gross-up payments Health or social club dues or initiation fees

Discretionary spending account Personal services (e.g., maid, chauffeur, chef)

If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain....

Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked in line 1a? ..

Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.

Compensation committee Written employment contract

Independent compensation consultant Compensation survey or study

Form 990 of other organizations Approval by the board or compensation committee

During the year, did any person listed in Form 990, Part VII, Section A, line 1a with respect to the filing organization or a related organization:

Receive a severance payment or change-of-control payment? ................

Yes

Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........

Yes

Participate in, or receive payment from, an equity-based compensation arrangement? .........

If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.

Only 501(c)(3) and 501(c)(4) organizations only must complete lines 5-9.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:

The organization? ...........................

Any related organization? .........................

If "Yes," to line 5a or 5b, describe in Part III.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:

The organization? ...........................

Any related organization? .........................

If "Yes," to line 6a or 6b, describe in Part III.

For persons listed in Form 990, Part VII, Section A, line 1a, did the organization provide any non-fixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............

Yes

Were any amounts reported in Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III .............................

If "Yes" to line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50053T

Schedule J (Form 990) 2013

Page 2

Part II

Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.

For each individual whose compensation must be reported in Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.

(A) Name and Title		(B) Breakdown of W-2 and/or 1099-MISC compensation			(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation reported as deferred in prior Form 990
(A) Name and Title		(i) Base compensation	(ii) Bonus & incentive compensation	(iii) Other reportable compensation	(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation reported as deferred in prior Form 990
(1)JOHN R FERNANDEZPRESIDENT	(i) (ii)	694,419 0	98,240 0	810 0	184,446 0	23,217 0	1,001,132 0	0 0
(2)JOAN W MILLER MDDIRECTOR	(i) (ii)	0 672,191	0 73,339	0 19,822	0 35,115	0 23,610	0 824,077	0 0
(3)JOSEPH B NADOL JR MDDIRECTOR (until 2/28/2014)	(i) (ii)	0 705,204	0 36,150	0 32,190	0 35,115	0 23,731	0 832,390	0 0
(4)SUSAN WILLIAMSASST SEC/GC (UNTIL 8/7/13)	(i) (ii)	116,502 0	0 0	112,795 0	3,015 0	5,940 0	238,252 0	0 0
(5)MAUREEN KELLEYASST SECRETARY	(i) (ii)	179,931 0	4,500 0	389 0	7,773 0	22,455 0	215,048 0	0 0
(6)CAROLANN WILLIAMSCFO & VP FINANCE AND ADMIN	(i) (ii)	330,066 0	36,193 0	509 0	10,081 0	1,634 0	378,483 0	0 0
(7)BARBARA J SCULLYDIRECTOR PROF REV CYCLE	(i) (ii)	175,749 0	5,000 0	219 0	13,970 0	22,351 0	217,289 0	0 0
(8)EILEEN O LOWELLCNO & VP PAT CARE SVS	(i) (ii)	233,862 0	20,173 0	977 0	15,226 0	22,688 0	292,926 0	0 0
(9)ALAN K LONGVP RESEARCH ADMINISTRATION	(i) (ii)	190,360 0	18,727 0	18,754 0	8,592 0	1,034 0	237,467 0	0 0
(10)CHRISTINE REGANVP HUMAN RSRCS (until 8/9/13)	(i) (ii)	131,293 0	0 0	137,002 0	3,451 0	7,201 0	278,947 0	0 0
(11)KENNETH HOLMESCFO MEEA	(i) (ii)	230,478	65,904	18,385	16,044	22,840	353,651
(12)JEAN E MACQUIDDYVP OTOLARYNGOLOGY(UNTIL3/1/14)	(i) (ii)	236,808 0	7,226 0	3,685 0	26,610 0	8,676 0	283,005 0	0 0
(13)JEFFREY J PIKECHIEF OPERATING OFFICER	(i) (ii)	302,207 0	25,731 0	487 0	12,408 0	9,067 0	349,900 0	0 0
(14)JAVIER BALLOFFETVP OPHTHALMOLOGY(until 5/2/14)	(i) (ii)	235,087 0	0 0	20,476 0	15,952 0	22,874 0	294,389 0	0 0
(15)JENNIFER STREETVP COMMUNICATIONS & PLANNING	(i) (ii)	297,197 0	25,840 0	736 0	12,781 0	23,137 0	359,691 0	0 0
(16)MELISSA M PAULCHIEF DEVELOPMENT OFFICER	(i) (ii)	195,731 0	19,903 0	18,011 0	15,696 0	22,728 0	272,069 0	0 0
(17)PHILLIP C JOHNSONDIR FINANCIAL OPERATIONS	(i) (ii)	161,206 0	9,000 0	18,197 0	20,593 0	22,773 0	231,769 0	0 0
(18)RALPH T PELOSIDIRECTOR FACILITIES PLANNING	(i) (ii)	167,670 0	10,000 0	922 0	8,258 0	916 0	187,766 0
(19)MICHAEL RICCICHIEF INFORMATION OFFICER	(i) (ii)	216,788	10,000	210	8,886	22,738	258,622

Schedule J (Form 990) 2013

Page 3

Part III

Supplemental Information

Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II.
Also complete this part for any additional information.

Return Reference

Explanation

SCHEDULE J, PART I, LINE 4A:

In connection with her departure effective August 7, 2013, Susan Williams received 6 months of salary continuation. Amounts paid under this agreement in 2013 of $83,393 are included in part ii, column b(iii). In connection with her departure effective August 9, 2013, Christine Regan received a lump sum payment of $111,602 of severence representing 6 months of salary and a $2,500 payment. Amounts paid under this agreement in 2013 are included in part ii, column b(iii). SCHEDULE J, PART I, LINE 4B: John Fernandez participates in a Deferred Compensation arrangement with Massachusetts Eye and Ear. Under the agreement, Mr. Fernandez will be credited $150,000 for CALENDAR YEAR 2013. Each annual credit will vest on the fourth anniversary of the date such credit was made or upon (1) the attainment of the age of 65 while employed; (2) termination without cause or resignation for good reason; (3) death; (4) disability; or (5) change of control of MASSACHUSETTS Eye and Ear within the meaning of section 409A of the Internal Revenue Code. SCHEDULE J, PART I, LINE 7: The Board of Trustees of the Massachusetts Eye and Ear Infirmary, upon recommendations of the Compensation Committee, approve a bonus program for certain individuals listed on the Schedule J. The program requires that supervisory personnel make the determination of (1) eligibility and (2) amount of bonus dollars based on overall job performance. The CEO of the Infirmary has the authority to (1) overrule recommendations made by supervisors and (2) make bonus determinations for Vice President level personnel. The Compensation Committee of the board has the final authority for bonuses paid to the CEO as well as the Vice Presidents. Total Compensation for listed individuals, including bonus payments, was analyzed by independent compensation consultants, determined to be reasonable compensation, and approved by the Board. No compensation payment can be made in excess of these amounts.

Schedule J (Form 990) 2013

Additional Data

Software ID:
Software Version:

- TIN:

Schedule K
(Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Information on Tax Exempt Bonds

Complete if the organization answered "Yes" to Form 990, Part IV, line 24a. Provide descriptions,
explanations, and any additional information in Part VI.
SchKMediumBullet

Attach to Form 990. SchKMediumBullet

See separate instructions.
SchKMediumBullet

Information about Schedule K (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public
Inspection

Name of the organization
MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number
04-2103591

Part I

Bond Issues

(a) Issuer name		(b) Issuer EIN	(c) CUSIP #	(d) Date issued	(e) Issue price	(f) Description of purpose	(g) Defeased		(h) On behalf of issuer		(i) Pool financing
(a) Issuer name		(b) Issuer EIN	(c) CUSIP #	(d) Date issued	(e) Issue price	(f) Description of purpose	Yes	No	Yes	No	Yes	No
A	MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES	04-2456011	57586EWL1	09-29-2010	63,156,092	FACILITY IMPROVEMENTS		X		X		X
B	MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES	04-2456011	57586ELD1	03-22-2007	20,000,000	FACILITY IMPROVEMENTS		X		X	X
C	MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES	04-2456011	57586ELD1	02-25-2005	13,695,000	FACILITY IMPROVEMENTS		X		X	X

Part II

Proceeds

	A		B		C		D
	1 Amount of bonds retired . . . . . . . . . . . . . .	1,620,000		9,138,000		6,693,592
2 Amount of bonds legally defeased . . . . . . . . . . .	0		0		0
3 Total proceeds of issue . . . . . . . . . . . . . .	63,156,092		20,000,000		13,695,000
4 Gross proceeds in reserve funds . . . . . . . . . . . .	5,013,431		106,620		68,647
5 Capitalized interest from proceeds . . . . . . . . . . .	5,191,181		0		0
6 Proceeds in refunding escrows . . . . . . . . . . . .	0		0		0
7 Issuance costs from proceeds . . . . . . . . . . . .	1,243,623		100,000		68,475
8 Credit enhancement from proceeds . . . . . . . . . . .	0		0		0
9 Working capital expenditures from proceeds . . . . . . . . .	0		0		0
10 Capital expenditures from proceeds . . . . . . . . . . .	48,036,561		19,700,000		13,489,575
11 Other spent proceeds . . . . . . . . . . . . . .	0		93,380		68,300
12 Other unspent proceeds . . . . . . . . . . . . . .	3,671,296		0		0
13 Year of substantial completion . . . . . . . . . . . .	2010		2010		2009
	Yes	No	Yes	No	Yes	No	Yes	No
14 Were the bonds issued as part of a current refunding issue? . . . . .		X		X		X
15 Were the bonds issued as part of an advance refunding issue? . . . . .		X		X		X
16 Has the final allocation of proceeds been made? . . . . . . . .		X	X		X
17 Does the organization maintain adequate books and records to support the final allocation of proceeds? . . . . . . . . . . . . . .	X		X		X

Part III

Private Business Use

	A		B		C		D
	Yes	No	Yes	No	Yes	No	Yes	No
1 Was the organization a partner in a partnership, or a member of an LLC, which owned property financed by tax-exempt bonds? . . . . . . .		X		X		X
2 Are there any lease arrangements that may result in private business use of bond-financed property? . . . . . . . . .		X		X		X

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50193E

Schedule K (Form 990) 2013

Page 2

Part III

Private Business Use (Continued)

	A		B		C		D
	Yes	No	Yes	No	Yes	No	Yes	No
3a Are there any management or service contracts that may result in private business use of bond-financed property? . . . . . . . . . . . .		X		X		X
b If "Yes" to line 3a, does the organization routinely engage bond counsel or other outside counsel to review any management or service contracts relating to the financed property?
c Are there any research agreements that may result in private business use of bond-financed property? . . . . . . . . . . . . . . .		X		X		X
d If "Yes" to line 3c, does the organization routinely engage bond counsel or other outside counsel to review any research agreements relating to the financed property?
4 Enter the percentage of financed property used in a private business use by entities other than a section 501(c)(3) organization or a state or local government . .	0 %		0 %		0 %
5 Enter the percentage of financed property used in a private business use as a result of unrelated trade or business activity carried on by your organization, another section 501(c)(3) organization, or a state or local government . . . . . . .
6 Total of lines 4 and 5 . . . . . . . . . . . . .
7 Does the bond issue meet the private security or payment test? . . . . .		X		X		X
8a Has there been a sale or disposition of any of the bond financed property to a nongovernmental person other than a 501(c)(3) organization since the bonds were issued?. . . . . . . . . . . . . . . . .
b If "Yes" to line 8a, enter the percentage of bond-financed property sold or disposed of.
c If "Yes" to line 8a, was any remedial action taken pursuant to Regulations sections 1.141-12 and 1.145-2? . . . . . . . . . . . . .
9 Has the organization established written procedures to ensure that all nonqualified bonds of the issue are remediated in accordance with the requirements under Regulations sections 1.141-12 and 1.145-2? . . . . . . .	X		X		X

Part IV

Arbitrage

	A		B		C		D
	Yes	No	Yes	No	Yes	No	Yes	No
1 Has the issuer filed Form 8038-T? . . . . .		X	X		X
2 If "No" to line 1, did the following apply? . . . .
a Rebate not due yet? . . . . . . . .	X
b Exception to rebate? . . . . . . . .
c No rebate due? . . . . . . . .
If you checked "No rebate due" in line 2c, provide in Part VI the date the rebate computation was performed
3 Is the bond issue a variable rate issue? . . . .		X	X		X
4a Has the organization or the governmental issuer entered into a qualified hedge with respect to the bond issue?		X		X		X
b Name of provider . . . . . . . . .	0		0		0
c Term of hedge . . . . . . . . . .
d Was the hedge superintegrated? . . . .
e Was the hedge terminated? . . . . . .

Schedule K (Form 990) 2013

Page 3

Part IV

Arbitrage (Continued)

	A		B		C		D
	Yes	No	Yes	No	Yes	No	Yes	No
5a Were gross proceeds invested in a guaranteed investment contract (GIC)? . . . . . . . . .		X		X		X
b Name of provider . . . . . . . . .	0		0		0
c Term of GIC . . . . . . . . . .
d Was the regulatory safe harbor for establishing the fair market value of the GIC satisfied? . . . . .
6 Were any gross proceeds invested beyond an available temporary period? . . . . . . . .		X		X		X
7 Has the organization established written procedures to monitor the requirements of section 148? . . .		X		X		X

Part V

Procedures To Undertake Corrective Action

	A		B		C		D
	Yes	No	Yes	No	Yes	No	Yes	No
Has the organization established written procedures to ensure that violations of federal tax requirements are timely identified and corrected through the voluntary closing agreement program if self-remediation is not available under applicable regulations?	X		X		X

Part VI

Supplemental Information. Provide additional information for responses to questions on Schedule K (see instructions).

Return Reference	Explanation
PART I, BOND (A), COLUMN (F):	THE PROJECT CONSISTS OF RENOVATION AND IMPROVEMENT OF EXISTING SPACE AND ACQUISITION OF MISCELLANEOUS EQUIPMENT LOCATED IN MEEI'S MAIN CLINICAL BUILDING, INCLUDING BUT NOT LIMITED TO THE FOLLOWING: THE AMBULATORY AND INPATIENT OPERATING ROOMS, THE SINUS CLINIC, THE NEURO-OPTHALMOLOGY CLINIC, THE OTOLARYNGOLOGY LASER CENTER, THE ENT CLINIC FOCUSING ON HEAD AND NECK CONDITIONS, THE PRE-ADMISSION TESTING SUITE, THE OPHTHALMOLOGY OUTPATIENT CLINICS LOCATED ON THE FIRST FLOOR, THE GROUND FLOOR (INCLUDING THE LOBBY AREA, EMERGENCY DEPARTMENT AND RADIOLOGY DEPARTMENT), THE PEDIATRIC OPHTHALMOLOGY CLINIC, THE HEAD AND NECK CLINIC, THE LASER CENTER, THE PEDIATRIC INPATIENT UNIT, THE OPHTHALMOLOGY PLASTICS OUTPATIENT CLINIC, THE OTOLARYNGOLOGY FACULTY OFFICE SUITE AND THE DESIGN AND ARCHITECTURAL FEES RELATING TO THE RECONSTRUCTING OF THE GROUND, FIRST, SECOND AND THIRD FLOORS FOR ADDITIONAL CLINICAL SPACE. IMPROVEMENTS TO EXISTING BUILDING INFRASTRUCTURE. PLANNING AND DESIGN COSTS RELATED TO A REPLACEMENT RESEARCH OR CLINICAL BUILDING TO BE LOCATED AT 309-325 CAMBRIDGE STREET. COSTS OF ISSUANCE AND CAPITALIZED INTEREST ON THE BONDS FINANCING THE PROJECTS DESCRIBED IN THIS SECTION FOR A PERIOD OF UP TO THREE YEARS.
PART I, BOND (B), COLUMN (F):	THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES.
PART I, BOND (C), COLUMN (F):	THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES.

Schedule K (Form 990) 2013

Additional Data

Software ID:
Software Version:

- TIN:

Schedule L
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Transactions with Interested Persons

Complete if the organization answered
"Yes" on Form 990, Part IV, lines 25a, 25b, 26, 27, 28a, 28b, or 28c,
or Form 990-EZ, Part V, line 38a or 40b.
MediumBullet

Attach to Form 990 or Form 990-EZ. MediumBullet

See separate instructions.
MediumBullet

Information about Schedule L (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Excess Benefit Transactions (section 501(c)(3) and section 501(c)(4) organizations only).
Complete if the organization answered "Yes" on Form 990, Part IV, line 25a or 25b, or Form 990-EZ, Part V, line 40b.

1(a) Name of disqualified person	(c) Description of transaction	(d) Corrected?
1(a) Name of disqualified person	(c) Description of transaction	Yes	No

Enter the amount of tax incurred by organization managers or disqualified persons during the year under section 4958. ........................... Bullet Image

Enter the amount of tax, if any, on line 2, above, reimbursed by the organization ....... Bullet Image

Part II

Loans to and/or From Interested Persons.
Complete if the organization answered "Yes" on Form 990-EZ, Part V, line 38a, or Form 990, Part IV, line 26; or if the organization reported an amount on Form 990, Part X, line 5, 6, or 22

(a) Name of interested person	(b) Relationship with organization	(c) Purpose of loan	(d) Loan to or from the organization?		(e)Original principal amount	(f)Balance due	(g) In default?		(h) Approved by board or committee?		(i)Written agreement?
(a) Name of interested person	(b) Relationship with organization	(c) Purpose of loan	To	From	(e)Original principal amount	(f)Balance due	Yes	No	Yes	No	Yes	No
(1) KENNETH HOLMES	KEY EMPLOYEE	HOUSING		X	50,000	10,000		No		No	Yes





Total ...... $						10,000

Part III

Grants or Assistance Benefitting Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 27.

(a) Name of interested person	(b) Relationship between interested person and the organization	(c) Amount of assistance	(d) Type of assistance	(e) Purpose of assistance

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 50056A

Schedule L (Form 990 or 990-EZ) 2013

Page 2

Part IV

Business Transactions Involving Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 28a, 28b, or 28c.

(a) Name of interested person	(b) Relationship between interested person and the organization	(c) Amount of transaction	(d) Description of transaction	(e) Sharing of organization's revenues?
(a) Name of interested person		(c) Amount of transaction	(d) Description of transaction	Yes	No
(1) JOAN MILLER MD	DRCTR IS LICENSOR TO ORG	177,331	PATENT LICENSE PROCEEDS		No

Part V

Supplemental Information
Provide additional information for responses to questions on Schedule L (see instructions).

Return Reference	Explanation
SCHEDULE L, PART V, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS	(A) NAME OF PERSON: JOAN MILLER, MD (D) DESCRIPTION OF TRANSACTION: INVENTOR PROCEEDS FOR PATENT RIGHTS ARE MADE IN ACCORDANCE WITH WRITTEN MEEI POLICY IN RESPECT OF INTELLECTUAL PROPERTY.

Schedule L (Form 990 or 990-EZ) 2013

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or to provide any additional information.
MediumBullet

Attach to Form 990 or 990-EZ.
MediumBullet

Information about Schedule O (Form 990 or 990-EZ) and its instructions is at
www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public
Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Return Reference	Explanation
FORM 990, PART I, LINE 1 & PART III, LINE 1:	THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") IS A NOT-FOR-PROFIT TEACHING HOSPITAL CONDUCTING PATIENT CARE AND RESEARCH. THE INFIRMARY IS A TEACHING HOSPITAL OF HARVARD MEDICAL SCHOOL AND AN INTERNATIONAL CENTER FOR RESEARCH. IT HAS THE MOST COMPETITIVE PROGRAM IN THE COUNTRY FOR EYE, EAR, NOSE, AND THROAT RESIDENCY TRAINING AND THE WORLD'S LARGEST OPHTHALMIC FELLOWSHIP PROGRAM. IT IS PART OF A SYSTEM OF RELATED ENTITIES THAT PROVIDE SPECIALIZED MEDICAL CARE COLLECTIVELY KNOWN AS "MASSACHUSETTS EYE AND EAR INFIRMARY" ("MEEI").
FORM 990, PART III, LINE 4A:	RESEARCH Ophthalmology: - ORMI Researchers First to Regrow Human Corneal Tissue Bruce Ksander, PhD and postdoctoral fellow Evi Kolovou, MD, as well as other ORMI members -James Zieske, PhD and Meredith Gregory-Ksander, PhD- have identified a way to enhance regrowth of human corneal tissue and restore vision, using a molecule known as ABCB5 that acts as a marker for rare limbal stem cells. Drs. Ksander and Kolovou were able to use antibodies detecting ABCB5 to zero in on the stem cells in tissue from deceased human donors, and use them to regrow anatomically correct, fully functional human corneas in mice. The ability to prospectively identify and isolate limbal stem cells will greatly enhance the success of corneal regeneration in patients with a limbal stem cell deficiency. -Researchers demonstrate drug-eluting lens can deliver sustained glaucoma medication for one month Joseph Ciolino (Cornea Center of Excellence) has worked closely with collaborators at Boston Children's Hospital and MIT to develop a drug-eluting contact lens that can deliver various pharmaceutical agents at a therapeutic rate every day for a full month. Recently, he and colleagues demonstrated for the first time the ability of the lens to deliver lantanopost, a common glaucoma medication. This is exciting news with potentially many therapeutic applications that could benefit a broad and diverse patient population.
Ocular Genomics Institute:	-The OGI Genomics Core provides state-of-the-art genomics services to members of the Department of Ophthalmology at Mass. Eye and Ear and Harvard Medical School. Services are also available to external academic investigators and commercial entities. In the past year, the Genomics core has performed genomic analyses of over 800 samples and sequencing of over 35,000 samples in support of research of many department members. The Genomics Core recently initiated whole genome sequencing using a non-amplified sample preparation method. Investigators who have utilized genomics core services are also working with the Mass. Eye and Ear Bioinformatics Center to analyze these data. -Genetic diagnostic testing: Through a CLIA-certified service, the OGI offers comprehensive genetic diagnostic testing for inherited eye diseases, including inherited retinal degenerations (IRDs), optic atrophy and glaucoma via the Genetic Eye Disease (GEDi) test. In the past year, over 250 samples submitted by investigators at MEEI and from outside institutions, have been analyzed using this test. A manuscript describing the performance of the GEDi test, which is highly accurate and reproducible, has been accepted for publication in the Nature journal Genetics in Medicine. -The Mass. Eye and Ear Bioinformatics Center, led by Dr. Xiaowu Gai, is supporting multiple investigators in the Department of Ophthalmology by providing broadly enabling bioinformatics expertise, infrastructure and shared resources. In addition, Dr. Gai co-leads an international consortium named Mitochondrial Disease Sequence Data Resource (MSeqDR) Consortium. This is a grass-root efforts involving over 100 international mitochondrial disease experts aiming to develop a centralized genomic resource for mitochondrial disease research, which has been designed, developed, and implemented by the MEEI Bioinformatics Center and is currently available online at https://mseqdr.org/. A review paper on MSeqDR was recently accepted by the journal Molecular Genetics and Metabolism. The United Mitochondrial Disease Foundation has also committed to continuous support for the project. -Gene Therapy Center, encompassing the research laboratory of Dr. Luk Vandenberghe and the Gene Transfer Vector Core, under the wider OGI umbrella. The Gene Transfer Vector Core (GTVC), which is directed by Drs. Vandenberghe and Ru Xiao is actively providing research-grade gene therapy vectors to Department and community investigators. Consultation regarding the design and execution phase of gene transfer experiments is also available. To date, the GTVC has generated over 400 adeno-associated virus preparations for about 24 research groups at MEEI, SERI, and outside research organizations. -Disease gene discovery: investigators in the OGI, led by Dr. Kinga Bujakowska in the Pierce lab, identified mutations in the IFT172 gene as a cause of inherited retinal degeneration. The studies reported in the journal Human Molecular Genetics showed that mutations in IFT172 can cause retinal degeneration alone, or in association with syndromic disease (published online August 2014). -Disease gene discovery: In a study published in JAMA Ophthalmology, the Engle Lab and members of OGI reported that mutations in the ryanodine receptor 1 (RYR1) cause of ophthalmoplegia, facial weakness, and malignant hyperthermia. This is important because total ophthalmoplegia can result from RYR1 mutations without overt skeletal myopathy. Patients carrying RYR1 mutations are at high risk of developing malignant hyperthermia. Ophthalmologists should be familiar with these important clinical associations. Date of publication: December 2013 (volume 131). -Phenotyping for future gene discovery: Moebius syndrome is a heterogeneous, rare congenital disorder defined by limited horizontal eye movement and facial weakness. To improve diagnostic assessment in Moebius syndrome, the Engle lab and members of the Department of Ophthalmology at CBH created more selective diagnostic subgroups and conducted genetic evaluation for three candidate genes in a cohort of 112 patients diagnosed with Moebius syndrome. They found that patients with exotropia, vertical gaze limitation, and ptosis did not have classic Moebius syndrome and most harbored TUBB3 mutations associated with CFEOM3. Thus, to optimize genetic analysis, they proposed adding "full vertical motility" to the minimum diagnostic criteria for Moebius syndrome. -Mechanism of disease: investigators in the OGI lead by Dr. Michael Farkas showed that mutations in genes that encode proteins called RNA splicing factors cause disease by disrupting the function of the retinal pigment epithelial cells of the retina. Mutations in RNA splicing factors are a common cause of inherited retinal degeneration. The findings, reported in the American Journal of Pathology in October 2014, provide important insight into way mutations in these genes cause vision loss, and make it possible to test treatments for these genetic forms of retinal degeneration. -Mechanism of disease: Members of the Engle lab previously reported that the ocular motility disorder ''Congenital fibrosis of the extraocular muscles type 1'' (CFEOM1) results from heterozygous mutations altering the motor and third coiled-coil stalk of the anterograde motor protein, KIF21A. In a study published this year in Neuron, they defined the oculomotor nerve developmental pathology of CFEOM1, established a gain-of-function mechanism for the disorder, and found that human motor or stalk mutations attenuate the autoinhibition of the Kif21a protein, providing in vivo evidence for mammalian kinesin autoregulation. Finally, they identified Map1b as a Kif21a-interacting protein and report that both CFEOM knock-in and Map1b knock-out mice also develop CFEOM. The interaction between Kif21a and Map1b highlights a selective vulnerability of the developing oculomotor nerve to perturbations of the axon cytoskeleton. Ocular Regenerative Medicine Institute: -Dean Eliott: Demonstrated survival of grafted embryonic stem cell derived RPE in AMD patients in a first-in-man trial. -Bruce Ksander, James Zieske: Identified limbal stem cells that repair and maintain the ocular surface. -Kip Connor, Neena Haider: Obtained funding from Brightfocus Foundation to pursue the development of a new genetic model for Choroidal Neovascular (wet) AMD. -Michael Young, Petr Baranov: Awarded the only vision related grant from the Bertarelli Program in Translational Neuroscience and Neuroengineering -James Zieske: Uncovered the function of thrombospondin-1 in repair of penetrating corneal wounds. -Darlene Dartt: Described the Role of PKC? activation in EGF-stimulated proliferation of rat and human conjunctival goblet cells. -Michael Young: Developed a novel stem cell therapy for retinitis pigmentosa using retinal progenitor cells, with a planned trial in 2015. -Demetrios Vavvas: Discovered that Mammalian STE20-like kinase 2, not kinase 1, mediates photoreceptor cell death during retinal detachment. -Petr Baranov and Michael Young: Described a novel substrate for the growth and maintenance of stem cells using polycaprolactone and RGB moieties. Infection Disease Institute: -The Gilmore Laboratory conducted the first genome analysis of Streptococcus pneumoniae from epidemic and non-epidemic conjunctivitis cases and identified a number of new virulence traits and vaccine candidates. -Michael Gilmore: Advised the President's Council of Advisors on Science and Technology about the problem of antibiotic resistance, which led to their "Report the President on Combating Antibiotic Resistance." http://www.whitehouse.gov/sites/default/files/microsites/ostp/PCAST/pcast_ carb_report_sept2014.pdf. -Michael S. Gilmore, James Chodosh, Marlene Durand, Wolfgang Haas: Launched the IDI January 1, 2014, and already have analyzed and archived over 1,000 bacterial specimens infections treated at Mass. Eye and Ear. -The Gilmore Laboratory conducted the first comprehensive genome-wide scans to identify traits of Staphylococcus aureus that are important in ocular as well as other infections. -The Gilmore Laboratory showed that antibiotic resistant strains of a leading cause of multidrug resistant hospital infection, Enteroccoccus faecium, derived from animal strains and not human commensal strains. Moreover, we showed that animal and human strains diverged about 3,000 years ago, as humanity began living in cities away from animals, and learned basic hygiene practices. -Michael S. Gilmore, James Chodosh, Marlene Durand, Lucia Sobrin, Wolfgang Haas: Began to develop and implement new diagnostic tests to detect difficult-to-diagnose infections of the eye. -Michael S. Gilmore, James Chodosh, Klaes Dohlman, Wolfgang Haas: Established new partnerships to improve the antimicrobial properties of ocular prosthetic devices. AMD Center of Excellence: -Kip Connor, Joan Miller, Demetrios Vavvas: Demonstrated that the receptor-interacting protein (RIP) ki
Glaucoma Center of Excellence:	-Working collaboratively with members of the Cornea Center of Excellence, members of the Glaucoma Center of Excellence described: -The functioning of a prosthesis embedded in an intraocular lens implant that wirelessly transmits information on the level of intraocular pressure. -The clinical course of keratoprosthesis glaucoma, recommending that glaucoma surgery be completed before, or combined with keratoprosthesis implantation. -Working with collaborators at the University of Illinois, Dr. Pasquale described a heighted risk of open angle glaucoma among women with early oophorectomy. -Working with collaborators from University of Michigan, Dr. Pasquale reported on an association between postmenopausal estrogen used and reduced risk of open-angle glaucoma using a healthcare relational database. -Dr. Janey Wiggs led an effort to describe the features of the LOXL1 knockout mouse, a murine model that shares some features with human exfoliation syndrome. This work was conducted in collaboration with members of the Retina Center of Excellence. -Drs. Pasquale and Wiggs working collaboratively with members of the Channing Division of Network Medicine at Brigham and Women's Hospital, described several modifiable risk factors for exfoliation glaucoma including time spent outdoors, lower dietary folate intake and high coffee consumption, using data from the Nurses Health Study and Health Professionals' Follow-up Study. With respect to time spent outdoors, Dr. Pasquale, along with several members of the Glaucoma Center of Excellence and faculty from the Comprehensive Eye Service, confirmed that time spent outdoors was associated with increased risk of exfoliation syndrome using a case control group from Mass Eye and Ear Infirmary combined with a case control group from Israel. -Dr. Pasquale, along with Dr. Robert Ritch, published the proceedings of The Glaucoma Foundation Think Tank 2013 Meeting on Exfoliation Syndrome, entitled "Exfoliation Syndrome: What we know and where we need to go". -On behalf of the GLAUGEN (Glaucoma Genes and Environment) study and the NEIGHBOR (National Eye Institute Glaucoma Human Genetics Collaboration) consortium, Glaucoma Center of Excellence investigators described several genetic loci for intraocular pressure. -Under the direction of Dr. Wiggs, the GLAUGEN (Glaucoma Genes and Environment) study and the NEIGHBOR (National Eye Institute Glaucoma Human Genetics Collaboration) consortium, was successfully converted to the NEIGHBORHOOD - NEIGHBOR Heritable Overall Operational Database, the largest case control dataset for primary open-angle glaucoma (POAG) with genotype calls for >5 million loci. This powerful dataset has been used to achieve several important milestones: -The NEIGHBORHOOD highlighted several genetic biomarkers in the vascular tone pathway associated with POAG. -The NEIGHBORHOOD database was used to describe several biochemical pathways that are operative in POAG including the GABA metabolism pathway. -In a series of 3 publications in Nature Genetics, the NEIGHBORHOOD dataset contributed data to an international effort that led to the discovery and validation for new genetic loci related to intraocular pressure, cup disc ratio and POAG. -The NEIGHBORHOOD dataset contributed to an understanding of the functional significance of the SIX1/SIX6 genomic region in relation to POAG. -The NEIGHBORHOOD dataset was used to demonstrate the CAV1/CAV2 genomic region is associated with paracentral visual loss in POAG. -Various member of the Glaucoma Center of Excellence along with members from the Comprehensive Eye Service, contributed to a survey of pre-operative blood tests in primary open-angle glaucoma (POAG) patients versus cataract surgery patients. The work suggests that POAG patients have higher IgG levels, pointing to a humoral immune deviation in POAG. -Dr. Teresa Chen published 2 papers regarding computer-based imaging of the nerve fiber layer in glaucoma patients. -Dr. Angela Turalba published work indicating that subtenons triamcinolone is not a viable option to enhance outcomes for glaucoma patients requiring glaucoma drainage implants. -Members of the Glaucoma Center of Excellence team described the effect of brominidine, an alpha 2 agonist that demonstrated a neuroprotective effect in the Low Pressure Glaucoma Treat Study, on retinal vascular autoregulation in normal tension glaucoma patients. Diabetic Eye Disease Center of Excellence: -Mara Lorenzi: -In a preclinical study using the rat model of diabetic retinopathy, it was found that retinal vessels become dependent upon a small increase in TGF-beta signaling. Thus, regulation of the TGF-beta system may modulate the severity and progression of retinopathy. -A clinical study in type I diabetic patients is identifying a defective myogenic response to pressure of retinal arteries as both a marker of diabetic retinopathy risk and an accelerator of retinopathy (collaboration with Sobrin, Feke, and Pasquale). -Pat D'Amore, Joe Arboleda: Developed a new mouse model of mural cell deletion that replicates the early stages of diabetic microangiopathy in the adult retina. This new mouse model can be used to study acute changes related to loss of mural cells in the retinal microvasculature. -Andrius Kazlauskas: Vitreous is capable of inducing regression of neovessels, and this activity wanes as patients develop proliferative diabetic retinopathy (PDR). This suggests that PDR arises not only because of an accumulation of pro-angiogenic factors (such as VEGF) in vitreous. A decline in the vitreous's intrinsic ability to promote regression of neovessels may be an additional contributor. Such discoveries set the stage for subsequent studies to develop adjuvant therapies for patients with PDR. -Lucia Sobrin: In study of Korean patients with diabetes, it was determined that extensive capillary nonperfusion in the retina on fluorescein angiography greatly increased the risk of progression of chronic kidney disease. -Magali Saint-Geniez: Demonstrated that a deficiency in fatty acid binding protein 4 (FABP4) is protective against oxygen-induced retinopathy in mice, identifying FABP4 as a potential target of pathologic retinal angiogenesis in proliferative retinopathies. -Dean Eliott: Participated in the iDEAL Study, a phase 2 clinical trial investigating whether the drug iCo-007, an antisense inhibitor targeting the C-raf kinase messenger RNA, could help treat patients with type 1 or type 2 diabetes and diabetic macular edema. Ocular Oncology Center of Excellence: -Shizuo Mukai: -Developed an iPhone app for detection of leukocoria -Analysis of 25 year experience with proton bean therapy for retinoblastoma. -Demetrios Vavvas, Evangelos Gragoudas: Demonstrated the efficacy of Visudyne in retinoblastoma cell lines without need for photoactivation -Kathryn Colby, Fred Jakobiec: Characterized distinguishing clinical and immunochemical features of neoplastic epithelial lesions of the conjunctiva. -Shizuo Mukai, Fred Jakobiec: Developed a model for pathogenesis of infantile medulloepithelioma. -Suzanne Freitag (in progress): Retrospectively analyzed causes for and outcomes of orbital exenterations over the last 10 years -Kathryn Colby, Rebecca Stacy: Developed a collaboration with MGH Melanoma Center to evaluate the role of genetic mutations in prognosis of conjunctival melanoma. -Eleftherios Paschalis, Mien Hoang, Joan Miller, Evangelos Gragoudas, Demetrios Vavvas: Demonstrated that metformin, an anti-diabetic drug, inhibited the in vitro proliferation of retinoblastoma cells at levels well above those tolerated in vivo. This suggests that metformin's potential anticancer effects, observed in epidemiological studies, may be limited to specific tumor types and/or related to indirect mechanisms not observed under laboratory conditions. -Bruce Ksander, Joan Miller, Evangelos Gragoudas, Demetrios Vavvas: Demonstrated that aminoimidazole carboxamide ribonucleotide (AICAR), an AMP-dependent kinase (AMPK) activator, inhibits uveal melanoma cell proliferation partially though activating the AMPK pathway and downregulating cyclins A1 and D1. -Joan Miller, Evangelos Gragoudas, Demetrios Vavvas: Demonstrated a novel role of the YAP-TEAD pathway in retinoblastoma, and demonstrated the therapeutic potential of verteporfin as an adjuvant therapeutic tool in treating retinoblastoma patients. The clinically used photosensitizer verteporfin was found to be a potent inhibitor of retinoblastoma cell growth, disrupting proto-oncogenes downstream of the YAP-TEAD signaling pathway, and downregulating the pluripotential marker OCT4. -Yoshihiro Yonekawa, Ivana Kim, Evangelos Gragoudas, Frederick Jakobiec, Rebecca Stacy: Presented the first reported case of choroidal melanoma that developed a late recurrence and aggressive metastasis to the skull base without evidence of hepatic involvement, and described its clinical, pathologic, and genetic findings. The case was characterized by delayed on
OTOLARYNGOLOGY:	-Scientists Restore Hearing in Noise-Deafened Mice A team including M. Charles Liberman, Ph.D., have restored the hearing of mice partly deafened by noise, using advanced tools to boost the production of a key protein in their ears. By demonstrating the importance of the protein, called NT3, in maintaining communication between the ears and brain, these new findings pave the way for research in humans that could improve treatment of hearing loss caused by noise exposure and normal aging. Wan G, Gmez-Casati ME, Gigliello AR, Liberman C, Corfas G. Neurotrophin-3 regulates ribbon synapse density in the cochlea and induces synapse regeneration after acoustic trauma. Elife. 2014 Oct 20;3. -Audio games may improve hearing in noisy environments Daniel B. Polley, Ph.D., and colleagues have programmed a new type of game that has trained both mice and humans to enhance their ability to discriminate soft sounds in noisy backgrounds. Their findings were published in PNAS Online Early Edition the week of June 9-13, 2014. In the experiment, adult humans and mice with normal hearing were trained on a rudimentary 'audiogame' inspired by sensory foraging behavior that required them to discriminate changes in the loudness of a tone presented in a moderate level of background noise. Their findings suggest new therapeutic options for clinical populations that receive little benefit from conventional sensory rehabilitation strategies. Whitton JP, Hancock KE, Polley DB. Immersive audiomotor game play enhances neural and perceptual salience of weak signals in noise. Proc Natl Acad Sci USA. 2014 Jun 24;111(25):E2606-15. -FGF23 hormone deficiency may lead to hearing loss and malformation Fibroblast growth factor 23 (FGF23) is a circulating hormone important in mineral homeostasis. Abnormal serum levels of FGF23 result in systemic pathologies in humans and mice, including rickets and calcinosis. Konstantina Stankovic, M.D., Ph.D., and colleagues sought to uncover the role FGF23 plays in the auditory system due to similarities between ear and kidney development. They found that FGF23 is expressed throughout the cochlea in mice and demonstrated that complete loss of FGF23 causes profound deafness, while partial loss results in moderate hearing loss at high frequencies. These observations are consistent with mixed conductive and sensorineural pathology of both middle and inner ear origin. Loss of the hormone causes dramatic bone abnormalities. Given the extensive middle ear malformations and the overlap of FGF23 activity and Eustachian tube development, this work suggests a possible role for FGF23 in otitis media. Lysaght A, Yuan Q, Fan Y, Kalwani N, Caruso P, Cunnane M, Lanske B, Stankovic KM. FGF23 deficiency leads to mixed hearing loss and middle ear malformation in mice. Plos One 2014; 2014 Sep 22;9(9):e107681. -Decoding Sounds' Source Mitchell Day, Ph.D., and Bertrand Delgutte, Ph.D., gained new insight into how localized hearing works in the brain. In the experiment, they recorded the electrical activity of individual neurons in an essential lower-level auditory brain area called the inferior colliculus (IC), while an animal listened to sounds coming from different directions. They found that the location of a sound source could be accurately predicted from the pattern of activation across a population of less than 100 IC neurons - i.e., a particular pattern of IC activation indicated a particular location in space. Researchers further found that the pattern of IC activation could correctly distinguish whether there was a single sound source present or two sources coming from different directions. Day ML, Delgutte B. Decoding sound source location and separation using neural population activity patterns. J Neurosci. 2013 Oct 2;33(40):15837-47. -Researchers Show that Efferent Feedback Slows Cochlear Aging Stphane Maison, Ph.D., M. Charles Liberman, Ph.D., and colleagues have shown that the Olivocochlear (OC) efferent reflex dramatically slows age-related hearing loss. The team surgically lesioned the OC efferent reflex and tracked hearing changes in mice exposed only to quiet ambient noise. After a year, mice with normal OC systems did not show significant hearing loss, while those with a lesioned efferent reflex presented damages to hair cells and auditory-nerve synapses. The lack of OC efferent reflex had turned middle-age ears into senescent ears. Liberman MC, Liberman LD, Maison SF. Efferent feedback slows cochlear aging. J Neurosci. 2014 Mar 26;34(13):4599-607. -New Findings in Protective Mechanisms for Hearing Loss Mingqian Huang, Ph.D., Albena Kantardzhieva, Ph.D., M. Charles Liberman, Ph.D., Zheng-Yi Chen, Ph.D., and colleagues in the Eaton-Peabody Laboratories, have created a new mouse model in which, by expressing a gene in the inner ear hair cells, protects the mice from age-related hearing loss (ARHL) and noise-induced hearing loss (NIHL). Their research, described in the Sept. 18, 2013 issue of the Journal of Neuroscience, provides new insight into protec-tive mechanisms for hearing loss and suggests the potential for future molecular approaches, which may include gene therapy or medicine, to treat ARHL and NIHL. Huang M, Kantardzhieva A, Scheffer D, Liberman MC, Chen ZY. Hair cell overexpression of Islet1 reduces age-related and noise-induced hearing loss. J Neurosci. 2013 Sep 18;33(38):15086-94 Bioengineering: -Prototype Chip Makes Possible Fully Implantable Cochlear Implant Konstantina Stankovic, M.D., Ph.D. and colleagues have designed a protype system-on-chip (SoC) that could make possible a fully implanted cochlear implant. Presented on Feb. 11, 2014 at the IEEE International Solid State Circuits Conference in San Francisco. -Scientists Create New System that could be used to Treat Deafness, Other Genetic Conditions A team of Harvard and Massachusetts Eye and Ear researchers, including Zheng-Yi Chen, Ph.D., have developed a system that uses commercially available molecules called cationic lipids - long, greasy molecules that carry a positive charge - to efficiently deliver genome-editing proteins into cells, and have even demonstrated that the technology can be used to perform genome editing in living animals. Zuris JA, Thompson DB, Shu Y, Guilinger JP, Bessen JL, Hu JH, Maeder ML, Joung JK, Chen ZY, Liu DR. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol. 2014 Oct 30 Clinical Practice: -Researchers present new findings concerning the inner ear's response to cochlear implant electrodes. The surgical placement of a cochlear implant is considered to be the state-of-the-art treatment for bilateral profound sensorineural hearing loss in cases where a conventional hearing aid is no longer useful. In a recent paper published in the October 2014 issue of Otology and Neurotology, Mohammad Seyyedi, M.D., a research fellow, and Joseph B. Nadol, Jr., M.D., of the Otopathology Research Laboratory at Mass. Eye and Ear, published their findings concerning the pattern and degree of tissue response adjacent to a cochlear implant electrode in humans. The paper demonstrates that occasionally a severe inflammatory response may result from cochlear implantation, in turn resulting in failure of the implant. It is hoped that this study will focus attention on the need to identify materials and techniques that limit the inflammatory response of the inner ear to the presence of a cochlear implant. Seyyedi M, Nadol JB Jr. Intracochlear inflammatory response to cochlear implant electrodes in humans. Otol Neurotol. 2014 Oct;35(9):1545-51. -Aspirin Intake May Halt Growth of Vestibular Schwannomas Konstantina Stankovic, M.D., Ph.D., led a study that demonstrated, for the first time, that aspirin intake correlates with halted growth of vestibular schwannomas, a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus. Kandathil CK, Dilwali S, Wu CC, Ibrahimov M, McKenna MJ, Lee H, Stankovic KM. Aspirin intake correlates with halted growth of sporadic vestibular schwannoma in vivo. Otol Neurotol. 2014 Feb;35(2):353-7. -The Supraclavicular Artery Flap for Head and Neck Daniel G. Deschler, M.D., FACS was lead author on a study conducted on 45 patients with defects related to malignant and nonmalignant disease undergoing reconstructive surgery. The team demonstrated the versatility of the supraclavicular artery (SCA) flap in head and neck reconstruction and offered technical highlights to improve the efficiency of flap harvest. The SCA flap is said to be a versatile and reliable reconstructive option for head and neck defects. Emerick KS, Herr MW, Lin DT, Santos F, Deschler DG. Supraclavicular artery island flap for reconstruction of complex parotidectomy, lateral skull base, and total auriculectomy defects. JAMA Otolaryngol Head Neck Surg. 2014 Sep;140(9):861-6. doi: 10.1001/jamaoto.2014.1394. Radiology: -The radiologists wrote or participated in 35 papers inc
FORM 990, PART III, LINE 4B:	EDUCATION ACADEMIC PROGRAMS: OTOLARYNGOLOGY: - 18 RESIDENTS - 11 CLINICAL FELLOWS - 55 RESEARCH FELLOWS - 2 RESEARCH RESIDENTS OPHTHALMOLOGY: - 24 RESIDENTS - 24 CLINICAL FELLOWS - 117 RESEARCH FELLOWS Ophthalmology: Educational Highlights: - The ACGME conducted a site visit of the Ophthalmology Residency Training Program in October 2013, and in May 2014 the Residency Review Committee reviewed the findings and awarded the program an excellent four-year re-accreditation with a self-study scheduled for July 2018. - Several new clinical fellowships have been initiated: Medical Retina (Director: Deeba Husain), Inherited Retinal Degenerations (Director: Eric Pierce), Inherited Retinal Degenerations and Pediatric Medical Retina (Co-directors: Eric Pierce and Anne Fulton, Children's Hospital), and Vision Rehabilitation (Director: Mary Lou Jackson)
Symposia and Conferences:	-Inaugural ORMI symposium: Ophthalmology represents a valuable arena for advancing regenerative medicine due the anatomical isolation, physical accessibility and immune privilege of the eye. To synthesize the latest developments in this field, the HMS Department of Ophthalmology presented the first Symposium on Ocular Regeneration: Cell Therapy and Regeneration in the Retina. The symposium was held on October 23, 2014 and co-chaired by Michael Young, PhD and Demetrios Vavvas, MD, PhD who also co-direct the Ocular Regenerative Medicine Institute. Experts from around the world delivered thought-provoking presentations and engaged participants in insightful, open-ended panel discussions at the end of each moderated session. The wide array of topics ranged from refining surgical techniques in preclinical models to optimizing strategies for isolating, culturing, and preserving stem cells for cellular therapies. Speakers explored the fundamental mechanisms of neuronal death in a variety of eye diseases, including age-related macular generation (AMD), glaucoma, and retinitis pigmentosa. Although the meeting focused primarily on regeneration of the retina, investigations from other parts of the eye (including the cornea) yielded insight into regenerative and cell-based therapeutic strategies overall. Basic stem cell biology was also discussed, down to the genetics and epigenetic mechanisms of cellular reprogramming and homeostasis. Attendees described the symposium as "great" and "excellent" overall and "...a great opportunity to communicate with other scientist on a high level and to learn from them." -3rd International Biennial Symposium on AMD: On October 24-25, 2014, the HMS Department of Ophthalmology hosted the 3rd International Biennial Symposium on AMD, co-chaired by Joan Miller, MD, FARVO and AMD Center of Excellence co-directors Patricia D'Amore, PhD, MBA, FARVO and Ivana Kim, MD. Presentations focused on the pathogenesis of early AMD. The complement system, a component of innate immunity, featured prominently throughout the symposium. Additional immune-related topics discussed during the event included inflammasome activation and cellular immune modulators such as macrophages, microglial cells and mast cells. Other emerging topics that were covered included oxidative stress and micro RNAs as biomarkers and therapeutic targets in AMD. Researchers are also aggressively pursuing potential therapies for the atrophic or "dry" form of AMD. Areas of interest highlighted at the meeting included mechanisms of photoreceptor death and early-phase clinical investigation of stem cell therapy. The symposium drew nearly 250 participants. -Neuro-ophthalmology Fall Festival: This unique workshop provided a comprehensive overview on the diagnosis and management of common or important neuro-ophthalmic disorders, including optic neuritis, ischemic optic neuropathy, vertical diplopia, giant cell arteritis, idiopathic intracranial hypertension, neuro-ophthalmology of multiple sclerosis, and a variety of eye movement disorders. The course included case presentations and lectures by the faculty. -Annual Meeting and Alumni Reunion: More than 300 HMS Department of Ophthalmology faculty, alumni, and trainees gathered for a three-day festival of events that included the Annual Meeting and Alumni Reunion, tours of Mass. Eye and Ear and Schepens, a celebratory dinner, and visits to Fenway Park and the Museum of Fine Arts from June 20 to 22, 2014. On Friday, scientific lectures were given by 12 HMS faculty showcasing their current investigations in eye research. Topics spanned telemedicine for diabetic retinopathy, genetics of retinitis pigmentosa, advances in retinal imaging, resident education, and management of acute Steven's Johnson Syndrome in children. On Saturday, the Alumni Reunion included Dr. Joan Miller's update on the state of the department, alumni presentations, and the Distinguished Research and Clinical Achievement Award presentations. New Courses: -Uveitis Instruction Course: This day-long course reviews the diagnosis and treatment of common uveitis conditions and covers diagnostic testing, imaging and treatment approaches to ocular inflammatory disease. Invited faculty speakers will include uveitis specialists from Bascom Palmer, Cleveland Clinic, Emory and Weill Cornell in addition to uveitis faculty from Harvard Medical School. -Soft Tissue Suture Course: Junior residents from Harvard Medical School/Mass. Eye and Ear, Tufts University, Boston University, Brown University, and Yale University are invited to attend this course on the principles of soft tissue suturing and suture materials. Participants also attend a wet lab session with video and live instruction using pig feet and ears. OTOLARYNGOLOGY: -This year we celebrated the graduation of the class of 2014 at a June 27th ceremony held in the Meltzer auditorium. Our outstanding graduates included residents Megan M. Abbott, M.D., M.P.H., Gillian Diercks, M.D., Aaron K. Remenschneider, M.D., M.P.H., and Ahmad R. Sedaghat, M.D., Ph.D. -We also celebrated the graduation of eight clinical fellows: -Prabhat K. Bhama, M.D., M.P.H., Facial Plastic and Reconstructive Surgery -David H. Jung, M.D., Ph.D., Neurotology -Giant C. Lin, M.D., Rhinology -Joshua C. Meier, M.D., Rhinology -Paul M. Paddle, M.D., Laryngology -Derek J. Rogers, M.D., Pediatric Otolaryngology -Aaron D. Tward, M.D., Ph.D., Neurotology -Bharat B. Yarlagadda, M.D., Head and Neck/Microvascular -Following graduation, we welcomed several new trainees in otolaryngology at Mass. Eye and Ear. Four new residents joined the program, including Jennifer Fuller, M.D., Deepa Galaiya, M.D., Anuraag Parikh, M.D., and Sid Puram, M.D., Ph.D. -We also welcomed eight new clinical fellows: -Gillian Diercks, M.D., Pediatric Otolaryngology -Neerav Goyal, M.D., Head and Neck/Microvascular -Inna Hussain, M.D., Laryngology -Nathan Jowett, M.D., Facial Plastic and Reconstructive Surgery -Rahul Modi, M.D., Thyroid and Parathyroid Surgery -Aaron Remenschneider, M.D., M.P.H., Neurotology -Ahmad Sedaghat, M.D., Ph.D., Rhinology -William Yao, M.D., Rhinology -In other education news, we are enjoying our new state-of-the-art Otolaryngology Surgical Training Laboratory immensely and have held several major courses there over the past year, from resident dissection courses to CME courses with international attendees. -We're also extremely excited about the creation of a Fellowship for Balance and Vestibular Disorders, a one-year post-residency fellowship program based at Mass. Eye and Ear, to train qualified physicians in the diagnosis and management of patients with balance and vestibular disorders. The first fellow will be selected to start in July 2015. -New Textbook: Tessa Hadlock, M.D., and Mack Cheney, M.D., recently celebrated the release of Facial Surgery: Plastic and Reconstructive, published by CRC Press. The book provides basic knowledge in facial plastic surgery for residents as well as experienced practitioners. With detailed descriptions of the latest surgical techniques, it captures and highlights meaningful new surgical methods with a deliberate emphasis on evidence-based medicine. evidence-based medicine.
FORM 990, PART III, LINE 4C:	CLINICAL CARE Ophthalmology: -Mass. Eye and Ear acquired two private ophthalmology practices. To the west, the cornea and refractive surgery practice of Jonathan Talamo, MD, Kathryn Masselam Hatch, MD and Karen Zar, OD (now Mass. Eye and Ear, Waltham) offers a full range of specialty eye care, including cataract surgery, on-site laser vision correction, corneal crosslinking and optometric services. Extending to the south, Mass. Eye and Ear purchased Southern New England Retina Associates located in Providence, Rhode Island (now Mass. Eye and Ear, Providence) and Plainville, Mass. (now Mass. Eye and Ear, Plainville). Magdalena Krzystolik and Paul Greenberg specialize in the treatment of retinal diseases, including AMD, diabetic retinopathy and retinal detachment. -Mass. Eye and Ear faculty Roberto Pineda II, Ula Jurkunas, Kathryn Hatch and Peter Veldman, are among a handful of corneal surgeons on the East Coast with advanced training in Descemets Membrane Endothelial Keratoplasty (DMEK). Developed in the Netherlands six years ago, DMEK is the thinnest and most advanced form of corneal transplantation to date. In contrast to other partial thickness corneal transplant procedures, DMEK replaces only the diseased tissue without need for additional or redundant tissue, which allows for a more precise and anatomically correct approach. As a result, DMEK has demonstrated lower risk of rejection, faster recovery, and better vision (a higher percentage of patients achieve 20/20 vision) than prior forms of corneal transplant. Dr. Veldman, a cornea and refractive surgeon, recently returned from a year-long fellowship at a high volume DMEK center in Portland, Oregon. He plans to host visiting surgeons for observation of live DMEK surgery at Longwood, as well as simulated surgeries with whole eyes and transplant tissue in a lab setting. NEW EQUIPMENT & TECHNOLOGY: -Aura Laser - Morse Laser Center -Hopkins Telescope - Longwood -Fundus Lens - Retina Consultants -Microscope - Eye Plastics, Eye Pathology -Keeler Laser Indirect Ophthalmoscope- Morse Laser Center -Spectralis Optical Coherence Tomography - DeGunzberg Imaging Center -Fundus camera, triple port adapter, Sonomed Escalon - Retina Consultants -Computer Upgrades (#82) - Ophthalmology clinical support and administrative personnel -Camera - Resident use in Emergency Department -OPD Scan III & Software - Cornea Service -Visante Optical Coherence Tomography and Corneal Topography Sys - Longwood -Equipment Upgrades - new Waltham, Providence, Plainville offices -Beamsplitter/video system/monitor -Longwood
COMMUNITY SERVICE ACTIVITIES:	LOCAL/REGIONAL -Louis Pasquale served as the Massachusetts spokesperson for World Glaucoma Awareness Week. Support Groups: -Mass. Eye and Ear Eye Plastics hosted a quarterly Thyroid Eye Disease support group, which is led by Suzanne Freitag, MD. This support group is run in collaboration with the Graves Disease and Thyroid Foundation along with MGH endocrinology and Dr. Greg Randolph of Mass. Eye and Ear ENT. -Mass. Eye and Ear Vision Rehabilitation Support Group runs weekly for 8 weeks in the Vision Rehabilitation Clinic, and is led by a Mass. Eye and Ear social worker and a social worker who has low vision. -Vision and Hearing Screenings for Children and Young Adults,Neighborhood House Charter School (Dorchester) Community Forums, Lectures and Special Events: -Members of the Department participated for the second year at Stoneham Town Day on September 13, 2014 on the Stoneham Town Common. Thousands in the Stoneham and surrounding communities came out to join in the festivities which included over 100 exhibitors with lots of food and games for children and information for adults. The volunteers spread the word about our full-service facility on Montvale Avenue and our Retina Consultants on Woodland Road. Screenings: -Members of the department provided comprehensive eye exams to children and leaders-in-training at Camp Harbor View. Of the 113 screened, 20 were advised to see their own providers to address refractive errors and 17 were advised to seek follow-up by a pediatric ophthalmologist-two of whom needed urgent follow up. Camp Harbor View is an initiative of the not-for-profit Camp Harbor View Foundation, Inc. in partnership with the City of Boston and the Boys & Girls Clubs of Boston. The camp offers close to 800 children-ages 11 to 14 and living in Boston's at-risk neighborhoods-the opportunity to participate in a four-week program offering traditional "summer camp" activities. -Year-Up Vision Clinic - Caregivers at Mass. Eye and Ear, Longwood, teamed up with the Vision Coalition, a local nonprofit that performs vision screenings, to provide complete eye exams and eyeglasses for two groups of students from Year-Up Boston, an organization that empowers low-income young adults to leap from poverty to professional careers in one year. Twenty-three patients were examined and all left with the knowledge that they would soon receive the eyeglasses they need to see clearly and to succeed in school and in internships.
OTOLARYNGOLOGY:	-Mass. Eye and Ear recently opened a satellite office in Medford, Mass., with Mass. Eye and Ear general otolaryngologist H. Gregory Ota, M.D., serving as Medical Director of the practice. Dr. Ota has been on staff at Mass. Eye and Ear since 1986 and has served as Director of the Emergency Department's Otolaryngology Service since 2011. -We are also in the process of building an otolaryngology presence at Mass. Eye and Ear's Longwood office, with both ambulatory and operating room volume. Community Service Activities: -Faculty and staff in the Otolaryngology Department engage in a variety of community service activities throughout the year. From free, public cancer screenings for skin cancer and head and neck cancer to public seminars on hearing loss, sinus disease and thyroid cancer, our team is dedicated to promoting public health through prevention and raising awareness in the community. -Onsite Head and Neck Cancer Screening at main campus -Expanded Public Forums, including "Have You Heard" the "Sinusitis Seminar" and "Thyroid Conference" Anesthesiology: -Successful implementation of the Inpatient Hospitalist Service, a division of the Department of Anesthesia. Radiology: -New Equipment and Technology: -A trial of a 3D Accuitomo CT system was continued through FY14 and will continue for 1st quarter of FY15. The system will then be leased for next 3-years or until new technology on the cone beam becomes available. -Mass. Eye and Ear purchased and installed a brand-new CT-scan system - the GE Discovery CT 750 HD - in just one week. The new system offers fast, high resolution imaging and state-of-the-art dual energy allowing for improved quality and diagnostic capability. The new system also has allowed us to reduce the radiation dose on multiple exams, especially related to pediatrics. The new system went live on August 12th. -A new Philips EPIQ 5G Ultrasound System was also purchased and implemented. This system allows for unprecedented advances in premium ultrasound performance, exceptional image quality and intelligence that provides automated views and quantification. -The siting and evaluation process for a 2nd MRI system began in FY14 and further planning will continue in FY15.
FORM 990, PART VI, LINE 1A:	THE INFIRMARY'S BYLAWS STATE THE FOLLOWING: THERE SHALL BE AN EXECUTIVE COMMITTEE CONSISTING OF THOSE INDIVIDUALS WHO ARE SERVING AS MEMBERS OF THE EXECUTIVE COMMITTEE OF THE MEMBER. THE EXECUTIVE COMMITTEE SHALL HAVE THE POWER TO TRANSACT ALL EMERGENCY BUSINESS OF THE CORPORATION DURING THE PERIOD BETWEEN THE MEETINGS OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL ALSO TRANSACT SUCH BUSINESS, PERFORM SUCH DUTIES, AND EXERCISE SUCH POWERS AS MAY BE DIRECTED OR DELEGATED BY THE BOARD OF DIRECTORS FROM TIME TO TIME. THE EXECUTIVE COMMITTEE SHALL KEEP A RECORD OF ITS PROCEEDINGS. ALL ACTIONS OF THE EXECUTIVE COMMITTEE SHALL BE REPORTED TO THE BOARD OF DIRECTORS AT ITS NEXT REGULAR MEETING. FORM 990, PART VI, LINE 7A: THE GOVERNOR OF THE COMMONWEALTH HAS THE AUTHORITY TO APPOINT TWO DIRECTORS. THE BYLAWS OF THE INFIRMARY STATE THAT THE REMAINING DIRECTORS ARE THOSE INDIVIDUALS SERVING AS DIRECTORS OF ITS SOLE MEMBER, THE FOUNDATION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY, INC. ("THE FOUNDATION").
FORM 990, PART VI, LINE 7B:	THE FOUNDATION IS THE SOLE MEMBER OF THE INFIRMARY AND RETAINS THE AUTHORITY TO MAKE DECISIONS REGARDING THE INFIRMARY.
FORM 990, PART VI, LINE 11B:	THE INFIRMARY'S FORM 990 IS PREPARED BY PRICEWATERHOUSECOOPERS, LLP USING INFORMATION PREPARED BY MANAGEMENT. AFTER THE FORM 990 IS COMPLETED, IT IS REVIEWED BY THE DIRECTOR OF FINANCE OPERATIONS. THE FORM 990 IS THEN PRESENTED TO THE FINANCE COMMITTEE FOR REVIEW AND APPROVAL AS AUTHORIZED BY THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ARE ALSO GIVEN THE FORM 990 FOR REVIEW WITH TIME TO SUBMIT COMMENTS AND QUESTIONS BEFORE FINAL FILING.
FORM 990, PART VI, LINE 12C:	MEMBERS OF THE STAFF ARE REQUIRED TO DISCLOSE CONFLICTS OF INTEREST TO THEIR CHIEF OF SERVICE OR DEPARTMENT AND DIRECTOR OF LABORATORY/UNIT. MEMBERS OF THE BOARD OF DIRECTORS ARE REQUIRED TO DISCLOSE ANNUALLLY, IN WRITING, ANY INTERESTS THAT COULD GIVE RISE TO CONFLICTS. THE OFFICE OF THE INTERNAL LEGAL COUNSEL OBTAINS AND REVIEWS THE ANNUAL CONFLICTS OF INTEREST STATEMENTS SUBMITTED BY MEMBERS OF THE BOARD OF DIRECTORS, AND REPORTS ON THE SAME TO THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD. WITH RESPECT TO INTERESTS DISCLOSED BY BOARD MEMBERS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, THE INTERNAL LEGAL COUNSEL REVIEWS ALL TRANSACTIONS BETWEEN SUCH INTERESTS AND AFFILIATES OF THE INFIRMARY, TO DETERMINE WHETHER THESE TRANSACTIONS WERE CONDUCTED AT ARM'S LENGTH.
FORM 990, PART VI, LINE 15:	THE CHAIRMAN OF THE COMPENSATION COMMITTEE OF THE BOARD OF THE INFIRMARY PRESENTS A RECOMMENDATION TO THE COMPENSATION COMMITTEE WHO HAVE FINAL APPROVAL OF THE CEO'S BASE SALARY AND BONUS AMOUNT. THE CEO RECOMMENDS EXECUTIVE SALARIES TO THE COMPENSATION COMMITTEE OF THE BOARD WHO HAS FINAL AUTHORIZATION TO APPROVE IT. TOTAL COMPENSATION FOR THE CEO, CHIEFS AND VICE PRESIDENTS, INCLUDING BONUS PAYMENTS, INCLUDING COMPARABILITY DATA, IS ANALYZED BY INDEPENDENT COMPENSATION CONSULTANTS AND IS DETERMINED TO BE REASONABLE.
FORM 990, PART VI, LINE 19:	SUMMARIZED FINANCIAL STATEMENTS ARE AVAILABLE ON THE INFIRMARY'S WEBSITE: WWW.MASSEYEANDEAR.ORG. AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. THE INFIRMARY'S GOVERNING DOCUMENTS AND FORM 990 ARE AVAILABLE UPON REQUEST. THE CONFLICT OF INTEREST POLICY IS ALSO AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: PERIODIC PENSION PLAN COST $(7,956,773)

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 51056K

Schedule O (Form 990 or 990-EZ) 2013

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE R
(Form 990)

Department of the Treasury
Internal Revenue Service

Related Organizations and Unrelated Partnerships

Complete if the organization answered "Yes" on Form 990, Part IV, line 33, 34, 35b, 36, or 37.
MediumBullet

Attach to Form 990. MediumBullet

See separate instructions.
MediumBullet

Information about Schedule R (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047

2013

Open to Public Inspection

Name of the organization

MASSACHUSETTS EYE & EAR INFIRMARY

Employer identification number

04-2103591

Part I

Identification of Disregarded Entities Complete if the organization answered "Yes" on Form 990, Part IV, line 33.

(a) Name, address, and EIN (if applicable) of disregarded entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Total income	(e) End-of-year assets	(f) Direct controlling entity

Part II

Identification of Related Tax-Exempt Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Exempt Code section	(e) Public charity status (if section 501(c)(3))	(f) Direct controlling entity	(g) Section 512(b)(13) controlled entity?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Exempt Code section	(e) Public charity status (if section 501(c)(3))	(f) Direct controlling entity	Yes	No
(1) FDN OF THE MASS EYE & EAR INFIRMARYINC 243 CHARLES STREET BOSTON,MA02114 04-2785453	PARENT	MA	501(C)(3)	9	NA		No
(2) MASSACHUSETTS EYE & EAR ASSOCIATES INC 243 CHARLES STREET BOSTON,MA02114 22-2658209	PATIENT CARE	MA	501(C)(3)	9	FOUNDATION	Yes
(3) CIRCLE COMPANY INC 243 CHARLES STREET BOSTON,MA02114 04-2801791	TITLE HOLDING	MA	501(C)(25)	N/A	FOUNDATION	Yes
(4) EMBANKMENT SERVICES INC 14 DAVID G MUGAR WAY BOSTON,MA02114 04-3272865	SUPPORTNG ORG	MA	501(C)(3)	11 - TYPE 1	FOUNDATION	Yes
(5) MASS EYE & EAR INFIRMARY PENSION PLAN 243 CHARLES STREET BOSTON,MA02114 04-6067238	PENSION PLAN	MA	401(A)	N/A	NA		No
(6) SCHEPENS EYE RESEARCH INSTITUTE INC 20 STANIFORD STREET BOSTON,MA02114 04-2129889	RESEARCH	MA	501(C)(3)	7	FOUNDATION	Yes

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50135Y

Schedule R (Form 990) 2013

Page 2

Part III

Identification of Related Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a partnership during the tax year.

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(f) Share of total income	(g) Share of end-of-year assets	(h) Disproprtionate allocations?		(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	(j) General or managing partner?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(f) Share of total income	(g) Share of end-of-year assets	Yes	No	(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	Yes	No

Part IV

Identification of Related Organizations Taxable as a Corporation or Trust Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(e) Type of entity (C corp, S corp, or trust)	(f) Share of total income	(g) Share of end-of-year assets	(i) Section 512(b)(13) controlled entity?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(e) Type of entity (C corp, S corp, or trust)	(f) Share of total income	(g) Share of end-of-year assets	Yes	No

Schedule R (Form 990) 2013

Page 3

Part V

Transactions With Related Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34, 35b, or 36.

Note. Complete line 1 if any entity is listed in Parts II, III, or IV of this schedule.

Yes

1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?

a Receipt of (i) interest (ii) annuities (iii) royalties or (iv) rent from a controlled entity . . . . . . . . . . . . . . . . . . . . . . .

b Gift, grant, or capital contribution to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

c Gift, grant, or capital contribution from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

d Loans or loan guarantees to or for related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

e Loans or loan guarantees by related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

f Dividends from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

g Sale of assets to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

h Purchase of assets from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

i Exchange of assets with related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

j Lease of facilities, equipment, or other assets to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . .

k Lease of facilities, equipment, or other assets from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

l Performance of services or membership or fundraising solicitations for related organization(s) . . . . . . . . . . . . . . . . . . . .

m Performance of services or membership or fundraising solicitations by related organization(s) . . . . . . . . . . . . . . . . . . . .

Yes

n Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) . . . . . . . . . . . . . . . . . . . . .

o Sharing of paid employees with related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

p Reimbursement paid to related organization(s) for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

q Reimbursement paid by related organization(s) for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

r Other transfer of cash or property to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

s Other transfer of cash or property from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.

(a) Name of related organization	(b) Transaction type (a-s)	(c) Amount involved	(d) Method of determining amount involved
(1) SCHEPENS EYE RESEARCH INSTITUTE INC	B	1,216,859	CASH
(2) SCHEPENS EYE RESEARCH INSTITUTE INC	C	201,997	CASH
(3) SCHEPENS EYE RESEARCH INSTITUTE INC	P	1,247,274	CASH
(4) SCHEPENS EYE RESEARCH INSTITUTE INC	Q	841,786	CASH
(5) CIRCLE COMPANY INC	O	123,842	CASH
(6) CIRCLE COMPANY INC	Q	162,500	CASH
(7) EMBANKMENT SERVICES INC	Q	1,155,000	CASH
(8) EMBANKMENT SERVICES INC	O	1,376,520	CASH
(9) SCHEPENS EYE RESEARCH INSTITUTE INC	B	841,628	CASH
(10) MASS EYE & EAR PENSION PLAN	R	8,637,931	CASH
(11) MASS EYE & EAR ASSOCIATES	Q	29,853,316	CASH
(12) MASS EYE & EAR ASSOCIATES	B	4,526,953	CASH
(13) MASS EYE & EAR ASSOCIATES	C	423,233	CASH
(14) MASS EYE & EAR ASSOCIATES	O	9,372,368	CASH
(15) MASS EYE & EAR ASSOCIATES	R	7,720,720	CASH

Schedule R (Form 990) 2013

Page 4

Part VI

Unrelated Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990, Part IV, line 37.

Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.

(a) Name, address, and EIN of entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	(e) Are all partners section 501(c)(3) organizations?		(f) Share of total income	(g) Share of end-of-year assets	(h) Disproprtionate allocations?		(i) Code V?UBI amount in box 20 of Schedule K-1 (Form 1065)	(j) General or managing partner?
(a) Name, address, and EIN of entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	Yes	No	(f) Share of total income	(g) Share of end-of-year assets	Yes	No	(i) Code V?UBI amount in box 20 of Schedule K-1 (Form 1065)	Yes	No

Schedule R (Form 990) 2013

Page 5

Part VII

Supplemental Information

Provide additional information for responses to questions on Schedule R (see instructions).

Return Reference	Explanation
SCHEDULE R, PART V, LINE 15:	CONTRIBUTIONS REPRESENT AMOUNTS CONTRIBUTED BY THE INFIRMARY FOR EMPLOYEE RETIREMENT BENEFITS AS REQUIRED BY THE PENSION PLAN'S FUNDING POLICY.

Schedule R (Form 990) 2013

Additional Data

Software ID:
Software Version:

1	Briefly describe the organization’s mission or most significant activities: SEE SCHEDULE O.
2	Check this box
3	Number of voting members of the governing body (Part VI, line 1a) ........	3	21
4	Number of independent voting members of the governing body (Part VI, line 1b) .....	4	19
5	Total number of individuals employed in calendar year 2013 (Part V, line 2a) ......	5	1,993
6	Total number of volunteers (estimate if necessary) .............	6	257
7a	Total unrelated business revenue from Part VIII, column (C), line 12 ........	7a	0
b	Net unrelated business taxable income from Form 990-T, line 34 .........	7b

		Prior Year	Current Year
8	Contributions and grants (Part VIII, line 1h) .........	39,413,484	41,532,901
9	Program service revenue (Part VIII, line 2g) .........	164,905,375	170,833,796
10	Investment income (Part VIII, column (A), lines 3, 4, and 7d ) ....	1,067,489	1,702,348
11	Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e)	16,279,280	14,000,554
12	Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)...................	221,665,628	228,069,599
13	Grants and similar amounts paid (Part IX, column (A), lines 1–3 )...	16,717,561	17,798,238
14	Benefits paid to or for members (Part IX, column (A), line 4).....	0	0
15	Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10)	106,973,420	103,616,750
16a	Professional fundraising fees (Part IX, column (A), line 11e).....	278,479	190,046
b	Total fundraising expenses (Part IX, column (D), line 25) 2,145,325
17	Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e)....	98,774,910	106,456,236
18	Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25)	222,744,370	228,061,270
19	Revenue less expenses. Subtract line 18 from line 12.......	-1,078,742	8,329
		Beginning of Current Year	End of Year
20	Total assets (Part X, line 16).............	224,049,415	209,199,752
21	Total liabilities (Part X, line 26).............	187,529,630	180,665,195
22	Net assets or fund balances. Subtract line 21 from line 20.....	36,519,785	28,534,557

Sign Here

	Signature of officer	Date

	Type or print name and title


4a	(Code: ) (Expenses $ 42,489,205 including grants of $ 5,213,307 ) (Revenue $ 170,833,796 )
	SEE SCHEDULE O

4b	(Code: ) (Expenses $ 3,958,309 including grants of $ 3,693 ) (Revenue $ )
	SEE SCHEDULE O

4c	(Code: ) (Expenses $ 120,820,443 including grants of $ 12,581,238 ) (Revenue $ )
	SEE SCHEDULE O

4d	Other program services (Describe in Schedule O.)
	(Expenses $ including grants of $ ) (Revenue $ )
4e	Total program service expenses167,267,957

(A) Name and Title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)		(D) Reportable compensation from the organization (W- 2/1099-MISC)	(E) Reportable compensation from related organizations (W- 2/1099-MISC)	(F) Estimated amount of other compensation from the organization and related organizations
(A) Name and Title
(1) JOHN R FERNANDEZ........................................................................ PRESIDENT	37.0 .......................23.0	X	X	793,469	0	207,663
(2) WYCLIFFE GROUSBECK........................................................................ CHAIR	3.0 .......................7.0	X	X
(3) JONATHAN UHRIG........................................................................ TREASURER	3.0 .......................7.0	X	X
(4) LILY H BENTAS........................................................................ SECRETARY (until 4/29/14)	3.0 .......................7.0	X	X
(5) RICHARD H ALDRICH........................................................................ DIRECTOR	2.0 .......................2.0	X
(6) DEWALT PETE ANKENY........................................................................ DIRECTOR	2.0 .......................6.0	X
(7) JAMES CARLISLE........................................................................ DIRECTOR	2.0 .......................2.0	X
(8) CHARLES DE GUNZBURG........................................................................ DIRECTOR	2.0 .......................6.0	X
(9) SAMUEL FLEMING........................................................................ DIRECTOR	2.0 .......................2.0	X
(10) HARVEY FREISHTAT........................................................................ DIRECTOR	2.0 .......................2.0	X
(11) LYLE HOWLAND........................................................................ DIRECTOR	2.0 .......................2.0	X
(12) DIANE E KANEB........................................................................ DIRECTOR	2.0 .......................2.0	X
(13) JONATHAN KUTCHINS........................................................................ DIRECTOR	2.0 .......................4.0	X
(14) VICTORIA MCCULLOUGH........................................................................ DIRECTOR	2.0 .......................6.0	X
(15) JOAN W MILLER MD........................................................................ DIRECTOR	27.0 .......................33.0	X		0	765,352	58,725
(16) JOSEPH B NADOL JR MD........................................................................ DIRECTOR (until 2/28/2014)	29.0 .......................31.0	X		0	773,544	58,846
(17) ANNETTE NOVA........................................................................ DIRECTOR	2.0 .......................6.0	X			0	0

(A) Name and Title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)				(D) Reportable compensation from the organization (W- 2/1099-MISC)	(E) Reportable compensation from related organizations (W- 2/1099-MISC)	(F) Estimated amount of other compensation from the organization and related organizations
(A) Name and Title
(18) WILLIAM ROMAN........................................................................ DIRECTOR	2.0 .......................2.0	X
(19) FREDERICK THORNE........................................................................ DIRECTOR	2.0 .......................2.0	X
(20) KATHRYN VECELLIO........................................................................ DIRECTOR	2.0 .......................6.0	X
(21) EUGENE HILL........................................................................ Director	2.0 .......................2.0	X
(22) D BRADLEY WELLING MD........................................................................ Director (effective 3/1/14)	29.0 .......................31.0	X
(23) ROBERT ATCHINSON........................................................................ DIRECTOR (EFFECTIVE 3/4/14)	2.0 .......................2.0	X
(24) MAUREEN KELLEY........................................................................ ASST SECRETARY	53.0 .......................7.0		X			184,820	0	30,228
(25) CAROLANN WILLIAMS........................................................................ CFO & VP FINANCE AND ADMIN	49.0 .......................11.0		X			366,768	0	11,715
(26) MARTHA PYLE FARRELL........................................................................ Assistant Secretary	3.0 .......................57.0		X			61,106	0	6,629
(27) BARBARA J SCULLY........................................................................ DIRECTOR PROF REV CYCLE	30.0 .......................30.0			X		180,968	0	36,321
(28) EILEEN O LOWELL........................................................................ CNO & VP PAT CARE SVS	60.0 .......................			X		255,012	0	37,914
(29) ALAN K LONG........................................................................ VP RESEARCH ADMINISTRATION	30.0 .......................30.0			X		227,841	0	9,626
(30) KENNETH HOLMES........................................................................ CFO MEEA	30.0 .......................30.0			X		314,767		38,884
(31) JEAN E MACQUIDDY........................................................................ VP OTOLARYNGOLOGY(UNTIL3/1/14)	30.0 .......................30.0			X		247,719	0	35,286
(32) JEFFREY J PIKE........................................................................ CHIEF OPERATING OFFICER	60.0 .......................			X		328,425	0	21,475
(33) JAVIER BALLOFFET........................................................................ VP OPHTHALMOLOGY(until 5/2/14)	20.0 .......................40.0			X		255,563	0	38,826
(34) RALPH T PELOSI........................................................................ DIRECTOR FACILITIES PLANNING	60.0 .......................			X		178,592	0	9,174
(35) MICHAEL RICCI........................................................................ CHIEF INFORMATION OFFICER	60.0 .......................			X		226,998		31,624
(36) SUSAN WILLIAMS........................................................................ ASST SEC/GC (UNTIL 8/7/13)	49.0 .......................11.0				X	229,297	0	8,955
(37) CHRISTINE REGAN........................................................................ VP HUMAN RSRCS (until 8/9/13)	60.0 .......................				X	268,295	0	10,652
(38) JENNIFER STREET........................................................................ VP COMMUNICATIONS & PLANNING	60.0 .......................				X	323,773	0	35,918
(39) MELISSA M PAUL........................................................................ CHIEF DEVELOPMENT OFFICER	60.0 .......................				X	233,645	0	38,424
(40) PHILLIP C JOHNSON........................................................................ DIR FINANCIAL OPERATIONS	60.0 .......................				X	188,403	0	43,366

1b	Sub-Total................
c	Total from continuation sheets to Part VII, Section A....
d	Total (add lines 1b and 1c)............	4,865,461	1,538,896	770,251

				(A) Total revenue	(B) Related or exempt function revenue	(C) Unrelated business revenue	(D) Revenue excluded from tax under sections 512-514
1a	Federated campaigns..1a
b	Membership dues....1b
c	Fundraising events....1c
d	Related organizations...1d		14,230,399
e	Government grants (contributions)1e		16,028,150

f	All other contributions, gifts, grants, and similar amounts not included above1f		11,274,352

g	Noncash contributions included in lines 1a-1f:$
h	Total. Add lines 1a-1f.......			41,532,901
			Business Code
2a	INPATIENT AND OUTPATIENT		900099	152,017,245	152,017,245
b	RESEARCH INDIRECT REVENUE		900099	7,012,603	7,012,603
c	HEARING AID CENTERS		900099	4,194,583	4,194,583
d	CAFETERIA/FOOD SERVICE		900099	1,883,633	1,883,633
e	MISCELLANEOUS REVENUE		722210	5,725,732	5,725,732
f	All other program service revenue .
g	Total. Add lines 2a–2f........			170,833,796
3	Investment income (including dividends, interest, and other similar amounts).......			57,039			57,039
4	Income from investment of tax-exempt bond proceeds..			0
5	Royalties...........			14,000,554			14,000,554
		(i) Real	(ii) Personal
6a	Gross rents
b	Less: rental expenses
c	Rental income or (loss)	0	0
d	Net rental income or (loss).......			0
		(i) Securities	(ii) Other
7a	Gross amount from sales of assets other than inventory	1,645,309
b	Less: cost or other basis and sales expenses
c	Gain or (loss)	1,645,309
d	Net gain or (loss)..........			1,645,309			1,645,309
8a	Gross income from fundraising events (not including $ of contributions reported on line 1c). See Part IV, line 18 ..
	a
b	Less: direct expenses ...b
c	Net income or (loss) from fundraising events..			0
9a	Gross income from gaming activities. See Part IV, line 19 ...
	a
b	Less: direct expenses ...b
c	Net income or (loss) from gaming activities...			0
10a	Gross sales of inventory, less returns and allowances .
	a
b	Less: cost of goods sold ..b
c	Net income or (loss) from sales of inventory..			0
Miscellaneous Revenue			Business Code
11a
b
c
d	All other revenue ....
e	Total. Add lines 11a–11d ......			0
12	Total revenue. See Instructions......			228,069,599	170,833,796		15,702,902


				(A) Beginning of year		(B) End of year
1	Cash–non-interest-bearing .............			1,374,003	1	566,415
2	Savings and temporary cash investments .........			0	2	0
3	Pledges and grants receivable, net ...........			0	3	360,000
4	Accounts receivable, net .............			21,380,084	4	22,892,699
5	Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L ..................
				10,000	5	10,000
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L
				0	6	0
7	Notes and loans receivable, net .............			0	7	0
8	Inventories for sale or use ..............			2,302,498	8	3,028,866
9	Prepaid expenses and deferred charges ..........			4,078,975	9	4,195,936
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a	391,123,990
b	Less: accumulated depreciation .....	10b	255,776,662	138,441,661	10c	135,347,328
11	Investments—publicly traded securities ..........			0	11	0
12	Investments—other securities. See Part IV, line 11 .....			0	12	0
13	Investments—program-related. See Part IV, line 11 .....			0	13	0
14	Intangible assets ...............			0	14	0
15	Other assets. See Part IV, line 11 ...........			56,462,194	15	42,798,508
16	Total assets. Add lines 1 through 15 (must equal line 34)......			224,049,415	16	209,199,752
17	Accounts payable and accrued expenses .........			70,433,190	17	77,351,461
18	Grants payable .................			0	18	0
19	Deferred revenue ................			25,513,725	19	14,295,172
20	Tax-exempt bond liabilities .............			83,647,571	20	80,998,192
21	Escrow or custodial account liability. Complete Part IV of Schedule D..			0	21	0
22	Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
	persons. Complete Part II of Schedule L..........			0	22	0
23	Secured mortgages and notes payable to unrelated third parties ..			0	23	0
24	Unsecured notes and loans payable to unrelated third parties ....			0	24	0
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D....................			7,935,144	25	8,020,370
26	Total liabilities. Add lines 17 through 25.........			187,529,630	26	180,665,195
	Organizations that follow SFAS 117 (ASC 958), check here and complete lines 27 through 29, and lines 33 and 34.
27	Unrestricted net assets ..............			36,519,785	27	28,174,557
28	Temporarily restricted net assets ...........			0	28	360,000
29	Permanently restricted net assets ...........			0	29	0
	Organizations that do not follow SFAS 117 (ASC 958), check here and complete lines 30 through 34.
30	Capital stock or trust principal, or current funds ........				30
31	Paid-in or capital surplus, or land, building or equipment fund .....				31
32	Retained earnings, endowment, accumulated income, or other funds				32
33	Total net assets or fund balances ...........			36,519,785	33	28,534,557
34	Total liabilities and net assets/fund balances ........			224,049,415	34	209,199,752

1	Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes,"the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926)......................................	Yes	No
2	Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A).......................................	Yes	No
3	Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471)..............................	Yes	No
4	Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621)...............................................	Yes	No
5	Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships. (see Instructions for Form 8865)....................................	Yes	No
6	Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to file Form 5713, International Boycott Report (see Instructions for Form 5713)................................................	Yes	No